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Abstract 
Epidemiological research investigates the natural occurring variation of complex 
traits and the covariance between these traits in the general population. By doing so, 
epidemiological research is an important tool to understand influential factors on 
complex traits such as neuropsychiatric diseases and related phenotypes. However, 
epidemiological studies are challenged by interpretational difficulties and are often 
limited to inferential data analysis especially when based on a cross-sectional design. 
Different strategies exist to optimize the impact generated by such inferential data 
analyses. One strategy is to increase the depth of information by adding intermediate 
related traits, which is especially done in the field of genetics. However, complex 
covariance pattern typically underlie the relation between e.g. genotype, intermediate 
phenotype and primary phenotype of interest, which have to be resolved. In this 
situation, more complex analytical strategies might help to identify the most 
plausible model of relationship. The downside of these more comprehensive 
analytical models lies in the increase of model complexity, that might result in a less 
stable outcome. Finding a good balance between model complexity and analytical 
simplicity is a major challenge when performing combined analyses with several 
complex phenotypes. In the current thesis I presented three different works dealing 
with complex analytical strategies. The main goal behind all three of them was not to 
build up comprehensive theoretical frameworks, but to perform more preparatory 
analytical steps. The meta-analysis validated and extended a genetic association 
finding of the single nucleotide polymorphism rs17070145 with human memory 
performance by accumulating information of about 6 years of research performed 
worldwide. The heritability analysis verified that a common SNP-chip array is an 
appropriate dataset to perform more complex genetic analysis with human working 
memory performance measurements. The analysis of common epigenetic variation 
validates the DNA CpG methylation dataset in the context of complex analyses in 
mentally healthy young adults. Additionally, when comparing the three analyses, they 
also shed light on the varying complexity of putative intermediate phenotypes in 
human research. This knowledge can be used to build up comprehensive theoretical 
models and complex statistical analyses that combine several complex phenotypes.  
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1 Introduction 
Members of the same species show considerable variability in their appearance 
and behavior. This variability can be due to differences in environmental factors, 
genetic factors, as well as interactions within and between both of them. By randomly 
selecting samples from a population, one can determine the distribution of these 
traits, which is often conformable with a Gaussian distribution (Fisher, 1918; Lyon, 
2013). This implies that we are dealing with complex traits and that the observed 
variability is based on a larger number of independent influential factors (for a 
putative example see Figure 1). Epidemiological research investigates the natural 
occurring variation of complex traits and the covariance between these traits in the 
general population, and is mainly based on observations (Potter, 2001). 
 
Figure 1 Starting with a monomorphic trait in a group of 500 individuals (A), influential factors with an average 
effect-size of r = 0.01 were added with increasing numbers (B-D). An effect-size or r = 0.01 is considered as 
small, but realistic e.g. for genetic association studies (Lango Allen et al., 2010; Ripke et al., 2014). 
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In contrast to that experimental research typically applies an experimental 
manipulation that might introduce additional variation, which does not necessarily 
appear under natural conditions (for a putative example see Figure 2). This is 
typically done in animal research by systematically changing environmental or 
genetic factors. Examples are e.g. studies that investigate the cognitive development 
of animals in an enriched in comparison to a non-enriched environment. Another 
example is investigating the impact of a given gene by experimentally knocking out 
the gene or suppressing the gene function.  
 
Figure 2 Based on the data from Figure 1D, an additional binary grouping factor is added. The difference 
between the two groups corresponds to a large effect size. In (A) the distribution of the total sample is depicted. In 
(B) the distribution is depicted separately for the two groups.  
 
With respect to experimental manipulation, human research is obviously 
limited in its possibilities. Hence, epidemiological studies focusing on the variability 
and covariance observed under natural conditions are an important method to gain 
further insight into trait variability. Understanding these factors may allow shaping 
traits in a desired way in daily life or may allow preventing disease (Besen & Gan, 
2014; Schacter, 2013). As a concrete example, psychiatric disorders are complex traits 
(Gelernter, 2015; Preston & Weinberger, 2005; Ripke et al., 2014), for which we still 
lack sufficient pharmacological treatment (Papassotiropoulos & de Quervain, 2015). 
Understanding the influential factors of complex psychiatric disorders and related 
traits may allow finding appropriate treatment strategies (Gottesman & Shields, 1973; 
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Gottesman, 2003; Papassotiropoulos & de Quervain, 2011; Papassotiropoulos et al., 
2013). However, epidemiological studies are challenged by interpretational 
difficulties and are often limited to inferential data analysis (Leek & Peng, 2015) 
especially when based on a cross-sectional design. Here, the existence of covariance 
rarely allows to draw conclusions regarding the direction of effect or with respect to 
the exact nature of the covariance (Ioannidis, 2008; Potter, 2001; Smith et al., 2007; 
van der Sijde, Ng, & Fu, 2014), not even in the case of genetic association studies (van 
der Sijde et al., 2014).  
Different strategies exist to optimize the impact generated by such inferential 
data analyses. One possibility is to apply data-mining techniques such as factor-
analysis, cluster-analysis or multivariate linear modeling to identify more general and 
robust communalities and covariance patterns. Another approach is to add external 
annotation information to further weight and stratify the obtained association 
results. This is typically done in genetic association analyses, when it is possible to 
add functional information to the most-promising genetic findings. A third strategy is 
to increase the depth of information by adding intermediate related traits 
(Gottesman, 2003; Papassotiropoulos & de Quervain, 2015; van der Sijde et al., 
2014). As an example, when investigating memory performance, it is possible to add 
information from functional brain imaging data that has been recorded while 
performing the task. All these strategies aim at generating testable hypotheses for 
future studies. The gold standard is to investigate these newly generated hypotheses 
by using different research designs, such as longitudinal studies and studies 
emphasizing on experimental designs with humans and animals (Kramer, 1998), in 
order to validate the importance of the initial finding. 
To summarize, all the strategies mentioned above point to the fact that simple 
data analytical approaches might not be sufficient when investigating complex 
phenotypes in humans. Instead, more complex analytical strategies in combination 
with targeted longitudinal studies, experimental designs and animal research are the 
key factors to develop an in-depth understanding of the nature of complex traits 
(Mayr, 1997). This doctoral thesis aims at contributing to the fields of molecular and 
cognitive neuroscience by investigating the natural occurring variation of complex 
phenotypes in healthy young subjects. The phenotypes under investigation were 
human memory performance and human DNA (deoxyribonucleic acid) CpG (C-
Introduction 
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phosphate-G) methylation derived from blood, which are both related to 
neuropsychiatric disorders. The following analytical approaches have been used: a 
meta-analysis, a heritability estimation based on unrelated individuals and a large-
scale replication analysis. All three analyses are per se complex analytical strategies. 
In the scope of this thesis they were mainly done as independent validation steps 
before applying comprehensive modeling strategies that combine several complex 
phenotypes.   
This thesis is based on the following three publications. The letters indicate my 
contributions to each publication and are listed after each reference: A - Designed the 
experiment; B - Performed the experiment; C - Analyzed the data or contributed to 
the analysis; D - Wrote the paper or contributed to paper writing. 
• Milnik, A., Heck, A., Vogler, C., Heinze, H.-J., de Quervain, D.J.-F., 
Papassotiropoulos, A., 2012. Association of KIBRA with episodic and working 
memory: a meta-analysis. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 159B, 
958–69. doi:10.1002/ajmg.b.32101 (A-D) 
• Vogler, C., Gschwind, L., Coynel, D., Freytag, V., Milnik, A., Egli, T., Heck, A., 
de Quervain, D.J.-F., Papassotiropoulos, A., 2014. Substantial SNP-based 
heritability estimates for working memory performance. Transl. Psychiatry 4, 
e438. doi:10.1038/tp.2014.81 (C-D) 
• Milnik, A., Vogler, C., Demougin, P., Egli, T., Freytag, V., Heck, A., Peter, F., 
Spalek, K., de Quervain, D.J.-F., Papassotiropoulos, A., Vukojevic, V., in 
preparation. Common epigenetic variation in a European population of 
mentally healthy young adults. (A-D) 
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2 Theoretical Background 
2.1 Complex data analytics with complex phenotypes 
Endophenotype, intermediate phenotype and biomarker are related theoretical 
constructs used to describe the relationship between genetic variation and complex 
traits (Papassotiropoulos & de Quervain, 2015; van der Sijde et al., 2014). The 
terminology endophenotype was introduced by Gottesman and Shields in the 
seventies (Gottesman & Shields, 1973) and further adapted to the field of psychiatry 
(Gottesman, 2003; Papassotiropoulos & de Quervain, 2015). In the field of 
neuropsychiatric diseases, a suitable cognitive endophenotype has to fulfill several 
criteria: It has to be disturbed in diseases, it has to show a neuronal correlate that can 
be investigated further and it has to be heritable (Papassotiropoulos & de Quervain, 
2015). Furthermore, it is thought that the complexity of an intermediate phenotype is 
lower than the complexity of the disease itself and that it is positioned along the 
causative pathway between genotype and disease (Mark & Toulopoulou, 2015; 
Preston & Weinberger, 2005; Rasch, Papassotiropoulos, & de Quervain, 2010; 
Toulopoulou et al., 2015) (see Figure 3 ).  
Typically, complex covariance patterns underlie the relation between 
genotype, intermediate phenotype and primary phenotype of interest (Rasch et al., 
2010; Relton & Davey Smith, 2010; Smith et al., 2007), which have to be resolved. 
Applying more complex analytical approaches might help to identify the most-
plausible relationship (Schadt et al., 2005). However, comprehensive analytical 
models can also result in a less-well to understand outcome as well as in a reduced 
model stability, just because of the complexity of the model (Blalock, 1966; Kreft, 
Kreft, & de Leeuw, 1998). Finding a good balance between model complexity and 
analytical simplicity is a major challenge when it comes to suitable analytical 
strategies that combine several complex phenotypes. 
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Figure 3 Levels of analysis in genetic studies of episodic memory. At the level of genes, subjects are genotyped 
with regard to naturally occurring genetic variations in the human genome. On the level of brain circuits, 
neuroimaging is used to examine genotype-dependent differences in brain activity or functional coupling between 
brain regions (Rasch et al., 2010).1 In this schema, the brain circuit is an intermediate phenotype with respect to 
memory performance, whereas memory performance is also a putative endophenotype with respect to 
neuropsychiatric diseases. The schema further evaluates possible sample-sizes that are necessary for genetic 
association studies. In principle, the less complex a phenotype is, the smaller the necessary sample-size should 
be. 
 
Simplifying the research design is an appropriate strategy to circumvent 
overwhelmingly complex analytical situations. One possibility is to keep factors 
constant that are known to add variability to the dataset. An example might come 
from the field of neuropsychiatric diseases. Here, complex dependencies exist 
between the disease status, brain functioning and cognitive endophenotypes 
                                                   
1 Reprinted from NeuroImage, 53(3), Fig. 3, Rasch, B. et. al., Imaging genetics of cognitive functions: Focus on 
episodic memory, 870–877, 2010, with permission from Elsevier. 
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(Toulopoulou et al., 2015). Instead of investigating the association between disease 
status, intermediate phenotypes and genetic background at once in a population that 
includes affected individuals, it is also possible to choose a less complex study 
population: by focusing on healthy young subjects one avoids the confounding factor 
of disease status. The findings derived from healthy young subjects can be used to 
further test them for associations with disease status in independent populations 
(Heck et al., 2014, 2015). With this stepwise approach, one avoids overly complex 
dependencies between the related phenotypes within one study population. 
Another strategy is to carefully investigate and validate the input variables. 
This may e.g. allow reducing the complexity of the dataset by applying techniques of 
dimensionality reduction or by focusing on the most-promising phenotypes. 
Especially for comprehensive modeling strategies it is necessary to know the expected 
effect sizes and the biologically or environmentally driven variation in a given 
dataset. This allows estimating necessary sample-sizes as well as choosing 
appropriate analytical models. The here reported analyses were done to investigate 
and validate the complex phenotypes human memory performance and DNA CpG 
methylation before performing combined analyses and comprehensive modeling 
approaches.  
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2.2 Human memory performance  
Human memory performance is a complex behavioral phenotype (Cahill, 
McGaugh, & Weinberger, 2001; Papassotiropoulos & de Quervain, 2011). Several 
classification approaches exist to group distinct memory processes in homogenous 
entities, based on observations from lesion-studies or based on functional 
classifications (Eustache & Desgranges, 2008; Henke, 2010). Memory processes can 
be broadly distinguished in working memory and episodic memory. Both characterize 
quite different cognitive functions used in everyday life. Working memory describes a 
system that temporarily stores transitory information for manipulation (Miller, 
2013), whereas episodic memory describes the explicit memory of autobiographical 
events (Ferbinteanu, Kennedy, & Shapiro, 2006; Tulving, 2002). With these two 
definitions for working and episodic memory in mind, we used a rather simple 
classification to assign tasks to one of the two categories, based on the timing of 
stimulus presentation and the amount of distraction during the tasks:  (1) the more 
time elapses between the encoding and the retrieval of the stimuli and (2) the more 
cognitive distraction takes place in between the two, the lower is the working memory 
component of the task. The N-Back task represents a typical and widely used 
working-memory task, in which subjects have to keep a stream of items (e.g. numbers 
or letters) in mind and have to indicate items that have been already presented one, 
two or three items before. A typical episodic memory task is to ask participants to 
encode pictorial or verbal material and to freely recall this material after a break of 
several minutes or hours.  
To fulfill the criteria of a suitable cognitive endophenotype, memory 
performance has to be heritable, has to be impaired in disease and has to show a 
neuronal correlate that can be further investigated (Papassotiropoulos & de 
Quervain, 2015). For both memory domains, working and episodic memory it could 
be shown that they are heritable traits (h2 = 0.15 – 0.74) (Ando, Ono, & Wright, 2001; 
Calkins et al., 2010; Greenwood et al., 2011; Lee et al., 2012; Vinkhuyzen, van der 
Sluis, Boomsma, de Geus, & Posthuma, 2010; Volk, McDermott, Roediger, & Todd, 
2006; Wilson et al., 2011). The heritability estimates are comparable for men and 
women and are relatively stable across different age ranges of adults (Finkel & 
McGue, 1998; Finkel, Pedersen, & McGue, 1995; Johansson et al., 1999; Read et al., 
2006).  
Theoretical Background 
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Neuropsychiatric diseases typically go along with an impairment in cognitive 
functioning such as working and episodic memory (Barch & Smith, 2008; Elvevåg & 
Goldberg, 2000). A deficit in episodic memory performance is one of the key 
symptoms of dementia; however, impairments in episodic and working memory can 
also be observed in a variety of other neuropsychiatric diseases such as schizophrenia 
(Forbes, Carrick, McIntosh, & Lawrie, 2009; Mesholam-Gately, Giuliano, Goff, 
Faraone, & Seidman, 2009; Van Snellenberg, 2009), depression (Drevets, Price, & 
Furey, 2008; Marazziti, Consoli, Picchetti, Carlini, & Faravelli, 2010) and 
posttraumatic stress disorder (Samuelson, 2011). Especially for schizophrenia, there 
is evidence that also unaffected relatives show impairments in cognitive functioning 
(Conklin, Curtis, Calkins, & Iacono, 2005; Egan et al., 2001; Thompson, Watson, 
Steinhauer, Goldstein, & Pogue-Geile, 2005). 
For both episodic and working memory well described neuroanatomical 
networks are known, with the medial temporal lobe region (including the 
hippocampus) as key anatomical structure for episodic memory (Eichenbaum, 2013), 
and a frontoparietal network as key anatomical structure for working memory (Owen, 
McMillan, Laird, & Bullmore, 2005). Findings from several studies suggest that also 
shared neuroanatomical networks exist for these two domains (Bird & Burgess, 
2008; Lückmann, Jacobs, & Sack, 2014). Neuropsychiatric diseases and decline in 
cognitive functioning typically go along with an impairment of these key 
neuroanatomical regions (Drevets et al., 2008; Persson et al., 2012; Sperling et al., 
2010). 
Within the scope of this thesis, the meta-analysis verified KIBRA as a 
promising target gene for human episodic memory performance, and resulted 1) in 
realistic effect size estimates for future studies and 2) provided a hint that the 
association between the investigated genetic variant rs17070145 and memory 
performance is not exclusive for episodic memory performance. The heritability 
estimation 1) validated that human working memory performance measured with the 
N-Back task is a suitable phenotype for genetic association studies and 2) delivered 
realistic heritability estimates for the share of heritability that is captured by common 
single-nucleotide polymorphisms (SNPs). 
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2.3 DNA methylation  
Epigenetic regulation is known to be centrally involved in trait variability and 
disease etiology (Petronis, 2010). The DNA sequence itself as blueprint of the genetic 
code is relatively uniform and fixed for nearly all cells of an individual. Epigenetic 
mechanisms serve as filter for the genetic information to achieve differentiation on a 
phenotypic level between cells and over time. Adrian Bird defined epigenetics as “the 
structural adaptation of chromosomal regions so as to register, signal or perpetuate 
altered activity states” (Bird, 2007). Hence, from an intermediate phenotype 
perspective epigenetic modification is positioned between the genetic code and the 
phenotypic outcome and is also physically located very closely to the DNA sequence 
(see Figure 4). Despite this close connection to the DNA (Schalkwyk et al., 2010; 
Shoemaker, Deng, Wang, & Zhang, 2010), the epigenetic inheritance is less stable 
than the genetic counterpart and hence allows more rapid adaptation to the 
environment (Sollars et al., 2003). 
DNA CpG methylation is one epigenetic mechanism that can be investigated at 
both high resolution and throughput (Bibikova et al., 2011). Epigenome-wide 
association studies allow to investigate more in detail the link between structural 
genetic variation and complex phenotypes (Tan, Christiansen, von Bornemann 
Hjelmborg, & Christensen, 2015). However, due to the temporal dynamics of the 
signal, the tissue specificity and the reactivity to environmental changes (Bock, 2009; 
Ladd-Acosta et al., 2015; Lister et al., 2013; Spiers et al., 2015), the complexity of the 
CpG methylation signal is a challenge from both the analytical and the 
interpretational perspective (Bock, 2012). This is especially the case for studies 
investigating neuropsychiatric brain diseases or human cognition. These studies 
typically have to rely on blood as proxy tissue instead of directly investigating brain 
tissue (Hannon, Lunnon, Schalkwyk, & Mill, 2015). 
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Figure 4 Depicted are the epigenetic mechanisms histone modification and DNA methylation that are involved in 
the regulation of transcription from DNA to messenger RNA (mRNA). The mRNA gets translated into a protein 
product. Another regulator of the mRNA translation is microRNA (miRNA) that might also interact with DNA 
methylation and histone modification (text is adapted from Relton & Davey Smith, 2010). The graphic is taken 
from Relton & Davey Smith, 2010. 
 
There is evidence that epigenetic modification is involved in several 
neuropsychiatric diseases such as Alzheimer’s disease or schizophrenia (Lardenoije et 
al., 2015; Lunnon et al., 2014; Pidsley et al., 2014). Especially for the glucocorticoid 
receptor, there is convincing evidence that stress leads to an epigenetic modification 
of the receptor and that this is linked to stress-related neuropsychiatric diseases 
(Bockmühl et al., 2015; Jawahar, Murgatroyd, Harrison, & Baune, 2015; Palma-
Gudiel, Córdova-Palomera, Eixarch, Deuschle, & Fañanás, 2015; Vukojevic et al., 
2014). Another important feature of the CpG methylation signal is its robust 
association with age (Hannum et al., 2013; Horvath, 2013; Horvath et al., 2012). 
Both, the stress and age related alterations in CpG methylation point to the fact that 
the epigenome might be able to bridge the gap between the fixed genetic blueprint 
and the variability in cognition and disease status over time.  
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However, when investigating healthy young adults, we are focused on a rather 
homogenous and healthy population with a narrow age-range. Within this 
homogenous population it is important to evaluate in how far the signal derived from 
DNA CpG methylation still comprises biologically or environmentally driven 
variability that can be used for analyses with further complex phenotypes. 
Replication analyses are a suitable tool to differentiate between the biologically and 
environmentally driven variability (summarized as common variance), technical 
variability and random noise. Hence, before associating the CpG methylation signal 
with further complex phenotypes, like memory performance, it is necessary to 
investigate and validate the signal itself. Within the scope of this thesis, the analyses 
of the methylation data provided realistic estimates of the expected common 
variation of each methylation site in a population of healthy young adults. This 
information can be used e.g. to preselect promising methylation sites for further 
association studies. 
Methods 
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3 Methods 
3.1 Meta-analysis 
The issues of a suitable sample size and the lack of replication in molecular 
and cognitive neuroscience have been widely discussed (Button et al., 2013; IntHout, 
Ioannidis, Borm, & Goeman, 2015; Ioannidis, 2008; Ioannidis, 2014). These issues 
especially emerge in the field of genetics because of the very small effect sizes that can 
be expected for associations with complex traits (Lango Allen et al., 2010; Ripke et 
al., 2014; Visscher, 2008). Meta-analyses can be used to derive a summary statistic 
that accumulates the evidences from several studies and analyses that deal with a 
related research question. Hence, a meta-analysis is a suitable tool to verify a finding 
that was initially based on a rather small sample size and to provide more realistic 
effect size estimates for an association. Contrary to primary research, the analytical 
procedure of a meta-analysis is rather fixed and guidelines have been developed that 
should be followed when performing such an analysis (Moher, Liberati, Tetzlaff, & 
Altman, 2009).  
The typical analytical workflow comprises an in-depth literature search best 
based on different search engines to identify relevant publications (see Figure 5). Via 
a systematic review, these publications have to be screened iteratively to exclude 
irrelevant publications. The reasons for exclusion and inclusion of specific 
publications have to be explicitly stated in a reproducible manner. Depending on the 
research question, it might also be necessary to further classify the analytical 
outcome within each published finding to be able to perform sub-meta analyses. As 
an example, we classified the reported task-performances for the memory related 
meta-analyses in working memory and episodic memory related tasks. Because this 
process contains subjective decision processes of the researcher and might introduce 
unwanted biases, all these steps should be done completely independent by two 
persons. Ambiguous classifications should be discussed with a third independent 
person. The relevant information of each study needs to be extracted (see Figure 6) to 
assess the quality of the research and to retrieve the relevant statistics for the meta-
analysis. Again, to reduce any bias, two persons should independently follow through 
these steps.  
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Figure 5 Flow of information through the different phases of a systematic review. Text and graphic are taken from 
Moher et al., 2009. 
There are two main options for the meta-analysis itself named random-effect 
and fixed-effect meta-analysis. Random-effect but not fixed-effect meta-analysis can 
incorporate unequal variances between groups. This is especially important for 
genetic studies, where the included study populations might come from distinct 
ethnical groups or mixtures of ethnical groups. In this situation, a random-effect 
meta-analysis appears more appropriate because it will yield more conservative 
results in the presence of between-study heterogeneity (Hedges & Olkin, 1985; 
Ioannidis, Patsopoulos, & Evangelou, 2007). The choice of estimate to summarize the 
statistical effects is less critical, since these estimates can be transferred from one to 
another (Nakagawa & Cuthill, 2007). A standard algorithm for random-effect meta-
analysis is the DerSimonian-Laird algorithm (DerSimonian & Laird, 1986), although 
it has been criticized that this algorithm is suboptimal when the number of studies 
included in the analysis is low (Hedges & Olkin, 1985).  
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Figure 6 Checklist of items to include when reporting a systematic review or meta-analysis. Text and graphic are 
taken from Moher et al., 2009. 
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Although a meta-analysis accumulates findings from different publications, 
and hence also different research groups, populations and experimental settings, it is 
not free from biases like e.g. the winner’s curse phenomenon or publication bias. The 
scientific knowledge building cannot be seen as an independent process. Significant 
findings in a hot-topic field will stimulate adjacent research dealing with the same 
research questions. Unfortunately, the scientific publication procedure favors 
significant above non-significant findings and hence one cannot expect to accumulate 
all knowledge of a given association when performing a meta-analysis, but that there 
will be a bias towards positive findings especially at the beginning, which is called 
“proteus phenomenon” (Pfeiffer, Bertram, & Ioannidis, 2011).   
 
3.2 Heritability estimation 
Heritability of a complex trait is a prerequisite to perform genetic association 
studies with common genetic marker. Heritability estimates depend on the 
population under investigation as well as the environment (Visscher, Hill, & Wray, 
2008) and the method used to estimate the heritability (Mousseau & Roff, 1987). 
Typically, heritability estimates for phenotypic data in humans have been estimated 
by comparing correlations between relatives, where the extent of genetic relatedness 
is derived from the degree of relationship. One method is the parent-offspring 
regression (Mousseau & Roff, 1987), but it is also possible to estimate heritability by 
applying mixed-model approaches to pedigree data (Akesson, Bensch, Hasselquist, 
Tarka, & Hansson, 2008; Kruuk, 2004). To reduce confounding effects of the 
environment, a preferred method is to compare monozygotic with dizygotic twins. 
Most-recently, based on 14’558’903 twin pairs, also meta-heritability estimates have 
been estimated that accumulate heritability estimates of 17’804 traits from 2’748 
publications published between 1958 and 2012 (Polderman et al., 2015).  
Due to the larger sample-sizes that are now available for complex-trait 
analyses, it is also possible to derive heritability estimates from unrelated individuals 
based on common SNP arrays, the so-called SNP-chip heritability (Yang, Lee, 
Goddard, & Visscher, 2011). The basis of this method is also a linear mixed model, 
however this method estimates genetic variation captured by all SNPs. In contrast to 
that approach the methods applied to parent-offspring pairs and siblings estimate the 
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genetic variance based on the phenotypic correlation for these pairs. Hence, these 
methods capture the contribution of all variants within the genome and not only of 
common SNPs (Yang et al., 2011). For the SNP-chip heritability, it is important to 
note that the sample-size has to be large enough to retrieve 1) accurate enough 
heritability estimates and 2) standard errors that are small enough for testing of 
significance. This is especially important if the overall heritability is not that high. 
From the analyses performed for this thesis, a rough approximation is that the 
sample-size should be 2’000 subjects or more for traits with a medium (defined as h2 
0.3-0.5) heritability. 
Heritability estimates reflect the proportion of total variance of a phenotype 
that is attributable to genetic variation (e.g. in total or for common SNPs). If it comes 
to association studies and to the estimation of expected effect sizes, this is however a 
rather imprecise information (Visscher et al., 2008). Only in combination with the 
genetic architecture of a trait it is possible to make inferences about the expected 
effect sizes. Simply spoken, the higher the polygenicity is, the less contribution can be 
attributed to a single genetic factor.  
Most recently, a complementary method has been developed, called stratified 
LD (linkage disequilibrium) score regression. Here, by adding annotation 
information to the genetic variants it is further possible to test whether groups of 
genetic variants disproportionally contribute to the heritability estimates (Finucane 
et al., 2015). In their analyses, especially conserved variants contributed most to the 
heritability estimates of 17 complex diseases. The stratified LD score regression 
method is a very nice example about how annotation information can be used as an 
additional analytical layer to gain more insight into a scientific field. 
 
3.3 Replication studies 
Large-scale array platforms exist e.g. for SNP-data, CpG methylation data or 
gene expression data, which measure hundred thousands of single-site signals for 
each dataset. The basic principle of an array is that the signal of each site, like one 
SNP, one CpG or one gene-expression value, are measured with several probes on 
one array, with the probe being the smallest entity on the array (see Figure 7). All 
probes that measure one site are called probe-set. Different normalization and 
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summarization methods exist to retrieve an interpretable signal for all sites that are 
measured on one chip. These site-signals typically comprise variability based on 
biological or environmental factors, technical variability and noise. Replication 
analyses can be used to dissect the different variance components of array data 
(Allison, Cui, Page, & Sabripour, 2006; Altman, 2005). 
 
Figure 7 Generic and simplified concept of an array to measure e.g. SNPs, CpGs or gene-expression values. The 
smallest unit on the array is called a probe. Several probes together form a probe-set that measures the smallest 
interpretable unit of an array, like e.g. one specific SNP, CpG or expression values of one gene, which is called 
site. Normalization and summarization methods exist to generate for each site one interpretable signal that can be 
used for the downstream analyses. 
Replication analysis with array data can be done with different material, with 
different arrays, with different subjects and on different levels. In a technical 
replication, the same material from the same time-point and the same subject is 
processed independently at least two times with the same array, whereas in biological 
replication the same procedure is performed but with the material of multiple 
subjects (Allison et al., 2006). Biological replicates are necessary to draw inferences 
from a study population.  
Technical replication analyses are typically done on array level (Tylee, 
Kawaguchi, & Glatt, 2013), meaning that the signal of all sites is compared at once 
between two repeated measurements of an array. This method can also be used to 
compare signals between different platforms (for an example see Figure 8) and 
typically leads to very high confidence rates for DNA CpG methylation data (Bibikova 
et al., 2011; Sandoval et al., 2011). Technical replication analyses on array level 
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correspond to the comparison of profiles over all sites. Similar to a heritability 
estimate, this is a very general measurement and it is not possible to draw 
conclusions for each single site included in the analysis. However, high confidence 
rates on array level within but also between platforms are a prerequisite to perform 
more in-depth analyses of reproducibility e.g. on single-site level. 
Association studies are typically done with single sites and inferences are 
drawn from the whole group of biological replicates. Based on a suitable number of 
biological replicates for which also technical replicates are available, it is also possible 
to assess the reliability on single-site level. With this approach, we compare the two 
repeated measurements of one site between all biological replicates. The number of 
biological replicates in the analysis determines the power to detect sites that can be 
measured reliably at least to some degree (assuming an alpha-error of 5 % and the 
power to be 80%): Based on 48 biological replicates it is possible to detect an r of 
0.39 which corresponds to an explained variability of 15.3 %, whereas based on 96 
biological replicates it is possible to detect an r of 0.28  (explained variability of 
7.9 %). The reliability estimates derived from this analysis reflect the share of 
common variability in the signal that is based on differences in the biological or 
environmental background of the investigated population, but not due to technical 
variance or noise. 
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Figure 8 Correlation between HumanMethylation450 and HumanMethylation27 arrays. The plot illustrates the 
correlation of beta values between HumanMethylation450 and HumanMethylation27 arrays across 25’978 
different CpGs (Bibikova et al., 2011).2  
 
 
                                                   
2 Reprinted from Genomics, 98(4), Fig. 4, Bibikova M. et. al., High density DNA methylation array with single CpG 
site resolution, 288–295, 2011, with permission from Elsevier. 
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WWC1 was first implicated in human cognition through a
genome wide association study in 2006 that reported an associa-
tion of the intronic single nucleotide polymorphism (SNP)
rs17070145with episodicmemory performance.WWC1 encodes
the protein KIBRA, which is almost ubiquitously expressed.
Together with its binding partners, KIBRA is assumed to play
a role in synaptic plasticity. T-allele carriers of SNP rs17070145
have been reported to outperform individuals that are homozy-
gous for the C-allele in episodic memory tasks. Here we report
two random effects meta-analyses testing the association of
rs17070145 with episodic and working memory. All currently
available population-based association studies that investigated
effects of rs17070145 on episodic or working memory were
included in the analyses. Where performance measures for
multiple domain-specific tasks were available for a given study
population, averaged effect size estimates were calculated. The
performed meta-analyses relied on 17 samples that were tested
for episodicmemoryperformance (N¼ 8,909) and9samples that
had performed working memory tasks (N¼ 4,696). We report
a significant association of rs17070145 with both episodic
(r¼ 0.068, P¼ 0.001) and working memory (r¼ 0.035, P¼
0.018). In summary, our findings indicate that SNP
rs17070145 located within KIBRA explains 0.5% of the variance
for episodic memory tasks and 0.1% of the variance for working
memory tasks in samples of primarily Caucasian background.
! 2012 Wiley Periodicals, Inc.
Key words: WWC1; rs17070145; single nucleotide polymor-
phism; common variant; human
INTRODUCTION
Genome-wide association studies (GWAS) offer a hypothesis-free
approach to identify new genotype-phenotype associations by
simultaneously testing hundred thousands of genetic markers.
Yet, one of the key issues GWAS have to deal with is the multiple
testing burden that easily gives rise to false positive results. In order
to downsize the probability of false positive results, two major
strategies are commonly applied: A, conservative multiple testing
correction as for example Bonferroni correction and B, even more
important, replication of the observed association in independent
samples. In highly polygenic traits, single genetic variations are
expected to have small impact on the total variance. Given the
scenario of small to medium sample sizes with concurring true and
small effect sizes, the necessary correction for type I error inflation
comes along with a higher probability of overestimating the real
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effect size. Thus replication studies are hampered by the fact that
theymust be sufficiently powered inorder to be capable of detecting
also smaller effects.Despite the fact that recruiting large sample sizes
is challenging, the GWAS approach paves the way for an unbiased
view on the impact of the human genome on polygenic traits.
Heritability estimates for both episodic andworkingmemory are
substantial (h2 0.37–0.74%) [Volk et al., 2006; Greenwood et al.,
2011] and have not only been observed in healthy individuals
but also in patients with memory disorders, such as late onset
Alzheimer’s disease (AD; h2 0.42–0.47%) [Wilson et al., 2011].
Heritability formemory performance has also been estimated in an
African [Calkins et al., 2010] and a Japanese [Ando et al., 2001]
population with similar results (h2 0.32–0.5%) as in Caucasian
samples. The genetic effect is comparable for men and women
[Read et al., 2006], relatively constant across different adult age
groups [Finkel et al., 1995; Finkel and McGue, 1998], and also
present in the oldest old [Johansson et al., 1999].
In 2006, Papassotiropoulos et al. [2006] reported an association
of single nucleotide polymorphism (SNP) rs17070145 (T!C
substitution) with episodic memory (initial sample N¼ 333,
5min delayed free recall of words P¼ 4" 10#6, 24 hr delayed
free recall of words P¼ 0.002, averaged r¼ 0.22). This finding
was replicated in the frame of the initial study in two independent
samples (Europe and USA) of Caucasian genetic background
(European sample N¼ 424, 10min delayed free recall of pictures
P¼ 0.006, r¼ 0.13; US sample N¼ 256, 30min delayed free
recall of words P¼ 0.004, Buschke Selective Reminding Test
P¼ 5" 10#5, averaged r¼ 0.22). Triggered by the initial report,
further studies investigated a potential association of rs17070145
with a large variety of psychometric measures [Almeida et al.,
2008; Nacmias et al., 2008; Need et al., 2008; Schaper et al.,
2008; Bates et al., 2009; Jacobsen et al., 2009; Zhang et al., 2009;
Hayashi et al., 2010; Preuschhof et al., 2010; Vassos et al., 2010;
Yasuda et al., 2010; Burgess et al., 2011; Kauppi et al., 2011; S!edille-
Mostafaie et al., 2011; Wersching et al., 2011]. Although being
heterogeneous in respect to sample size and genetic background of
sampled populations, the association of rs17070145 with memory
performance could be replicated in independent studies and sam-
ples [Schaper et al., 2008; Almeida et al., 2008; Bates et al., 2009;
Preuschhof et al., 2010; Vassos et al., 2010; Yasuda et al., 2010;
Hayashi et al., 2010; Kauppi et al., 2011]. Non-replications were
also reported [Need et al., 2008; Nacmias et al., 2008; Bates et al.,
2009; Burgess et al., 2011; Wersching et al., 2011; S!edille-Mostafaie
et al., 2011].
In addition to the effect of rs17070145 on episodic memory,
some studies also detected a significant association betweenWWC1
and working memory performance, or tasks which feature an
overlap between episodic and working memory [Schaper et al.,
2008; Vassos et al., 2010; Yasuda et al., 2010; Kauppi et al., 2011].
Recent research provides evidence for the involvement of the
medial temporal lobe in working memory processes, besides its
long known critical role for episodic memory [Bird and Burgess,
2008; Ranganath, 2010]. Given the important role of KIBRA for
medial temporal lobe and hippocampal functioning as discussed in
the initial study [Papassotiropoulos et al., 2006], a potential role for
KIBRA in working memory can be considered as well. Behavioral
studies on memory in Caucasian populations suggest that T-allele
carriers outperform individuals that are homozygous for the
C-allele.
SNPrs17070145 resideswithin theninth intronofWWC1,which
is located on chromosome 5q34 and encodes the KIBRA protein.
KIBRA is almost ubiquitously expressed and is also present in
memory-related brain regions [Papassotiropoulos et al., 2006;
Johannsen et al., 2008]. Together with its binding partners, KIBRA
is assumed to play a role in synaptic plasticity [Schneider et al.,
2010]. For example, KIBRA interacts with PKMzeta, the brain-
specific atypical isoform of PKCzeta [B€uther et al., 2004; Schneider
et al., 2010], which is strongly associated with memory formation
and the maintenance of long-term potentiation (LTP). Further-
more, theWW domain allows KIBRA to interact with dendrin and
synaptopodin [Kremerskothen et al., 2003; Duning et al., 2008],
which play a role in synaptic plasticity, signal transduction and the
organization of the cytoskeleton [Herb et al., 1997; Kremerskothen
et al., 2006; Duning et al., 2008]. Additional interaction partners of
KIBRA are implicated in vesicle-based transport processes, cell
polarity, cell migration, and transcriptional regulation [Schneider
et al., 2010]. Recent in vitro and animal studies demonstrated that
KIBRA is part of an a-amino-3-hydroxy-5-methyl-4-isoxazole-
propionic acid receptor (AMPAR) protein complex, which regu-
lates AMPAR membrane trafficking. Adult KIBRA knockout
mice were viable, but exhibited deficits in hippocampal LTP and
long-term depression along with an impairment of learning and
memory [Makuch et al., 2011].
While deficits in episodic memory are a key symptom of de-
mentia, impairments in episodic andworkingmemory tasks can be
observed in a variety of neuropsychiatric disorders comprising
schizophrenia [Forbes et al., 2009; Mesholam-Gately et al., 2009;
Van Snellenberg, 2009], depression [Drevets et al., 2008; Marazziti
et al., 2010], and posttraumatic stress disorder [Samuelson, 2011].
Having been associated with memory performance in healthy
subjects, WWC1 thus also became a target for the investigation
of such disease-related phenotypes as mild cognitive impairment
[Almeida et al., 2008] and dementia [Rodr!ıguez-Rodr!ıguez et al.,
2009; Corneveaux et al., 2010; Hayashi et al., 2010; Burgess et al.,
2011]. In a meta-analytic approach that included 16 independent
samples, Burgess et al. [2011] could show a statistical trend for a
decreased risk of T-allele carriers for dementia (4,436 cases and
4,334 controls, protective Odds Ratio for T-allele 0.94, P¼ 0.07).
Taken together, the initial findings yielded by the GWAS ap-
proach in healthy individuals served as a starting point to further
investigate a potential association of KIBRA with susceptibility to
memory-related diseases [Burgess et al., 2011]. Recent studies also
suggested possible mechanisms [Schneider et al., 2010; Makuch
et al., 2011] through which KIBRA acts on memory.
The present study aimed at estimating a general effect size for the
association of the KIBRA SNP rs17070145 with episodic memory.
In addition, we investigated whether rs17070145 is also associated
with working memory. In order to achieve a task-independent, but
domain-specific measure for the effect sizes of theWWC1 SNP on
episodic and working memory, we averaged over all available
domain-specific performance-tests per sample. We included all
available samples that provide sufficient information for estimating
effect sizes. Since the included samples were heterogeneous
with respect to genetic background, health status, age range, and
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accomplished tasks, we performed random effects meta-analyses,
because this approach incorporates unequal variances between
groups. In the case of large between-study heterogeneity, random
effects meta-analysis will yield more conservative results in com-
parison to fixed effects meta-analysis [Ioannidis et al., 2007].
MATERIALS AND METHODS
Literature Search and Study Selection
PubMed- and Medline-based literature search was done in
November 2011 with ‘‘KIBRA’’ or ‘‘WWC1’’ as search terms
(Supplementary Fig. 1). Studies were included, if they provided
(I) a population-based association analysis that (II) comprised SNP
rs17070145and episodic orworkingmemory tasks and (III) applied
a T-dominant or additive genetic model. Furthermore the estima-
tion of effect sizes and confidence intervals required the following
information to be available (IV): Sample size, statistical model,
test statistic or P-value and direction of effect.
Data Extraction
All studies were screened by two authors (A.M., A.H.). Data were
independently extracted. For each study, we recorded name of first
author, publication year and number of independent samples
reported. For each sample, the following informationwas extracted
or calculated: Sample size, age-range and mean age, sample sizes of
genotype sub-groups (CC vs. CT vs. TT), genotyping method,
ethnicity, health status, collected psychometric measurements,
P-value for sex and age differences between genotype groups
(CC vs. CT/TT), P-value for Hardy–Weinberg equilibrium
(HWE). For each episodic andworkingmemory task, the following
information was extracted: Mean and standard deviation of per-
formance for the two genotype groups (CC vs. CT/TT), calculated
statistic model with included covariates, test statistics and P-value,
direction of effect. If necessary, corresponding authors were con-
tacted to provide missing information or to clarify inconclusive
information.
Selection of Psychometric Measurements
Two authors (A.M. and A.H.) independently assigned the reported
psychometric measurements to the following domains: Episodic
memory tasks, working memory tasks that feature a potential
overlap with episodic memory, pure working memory tasks, and
memory-unrelated tasks. Since the set-up ofworkingmemory tasks
has a potential influence on the involvement of different memory
components, we further subdivided tests which feature a potential
overlap with episodic memory in tasks with a marked working
memory component (below referred to as narrow-sense working
memory tasks), and tasks with a weaker working memory compo-
nent (below referred to as broad-sense working memory tasks).
Assignment to episodic memory, broad-sense working memory
and narrow-sense working memory domains was done as follows:
if the tasks comprised an interval of at least 3min or a distraction
between encoding and recall, it was allocated to episodic memory.
If no delay between encoding and recall was present, items to be
remembered were presented only once and stimulus material was
not requiringmultimodal processing (as would be the case for story
recall or tasks involving the performance of actions, termed
‘‘subject-performed tasks’’), then the task was allocated to narrow-
sense working memory. If delay between encoding and recall was
less than 3min, but stimulus material was presented and recalled
repeatedly or if the task included multimodal processing, then the
task was allocated to broad-sense working memory (see Supple-
mentary Table I). Allocation to the specific memory domains
was additionally discussed by three of the authors (A.M., A.H.,
and C.V.).
Quality Assessment
Given the reported effects of sex and age on cognitive performance
[Park et al., 2002; Read et al., 2006; Andreano and Cahill, 2009],
most studies included sex and age as covariates in their analysis.
Wherever reported sex or age effects between genotype groups
(CCvs. CC/TT)were far from significance (P> .25), we rather used
the uncorrected values for effect size estimation. In all other cases,
we preferred to use the statistics that were corrected for sex and
age. Wherever more than one linear model was calculated in the
scope of one analysis, we used those models recommended in the
respective studies (if recommendations were given).
Data Analysis
We used r as effect statistic estimate. The effect statistic r was
preferred over d, because r2 denotes the portion of phenotypic
variance that canbe explained by the genotypic variation.Wherever
only an additive genetic model was reported, r was directly esti-
mated from the regression coefficients of the linear model or
from P-values. Wherever a two-group comparison was reported,
we estimated Hedges d [Hedges and Olkin, 1985], since it is
corrected for a potential bias caused by small sample size. Hedges
d was preferentially estimated from standardizedmean differences,
t-values of two-sample t-tests, or P-values. If raw value information
was missing, or if relevant confounding effects of sex or age were
reported, Hedges d was estimated based on the following statistics:
(M)AN(C)OVA F-value, linear regression t-value, regression coef-
ficient or P-value. We corrected for the number of covariates used
and for unequal sample sizes between genotype groups, wherever
possible. Yet, given the allelic distribution in Caucasians, the effect
of correction for unequal sample sizes is nearly negligible, if the
T-dominant model (CC vs. CT/TT) was calculated. After estima-
tion and correction, we transformed Hedges d to the test statistic r.
If enough informationwas provided to calculate the estimates from
the additive or the T-dominant genetic model, we preferred the
T-dominant genetic model.
If one sample performed more than one episodic or working
memory task,we averaged the effect sizeover all episodicorworking
memory tasks, respectively.Wherever sample sizes differedbetween
tasks or tasks were performed in sub-samples only, we calculated a
meanweightedby the size of the sub-samples. Thusnobias favoring
the larger sample was introduced and the more accurate effect
size estimation for larger samples was taken into account. In this
scenario, we set the number of subjects equal to the N of the larger
sample. If follow-up measurements using the exact same task were
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reported, only the performance at the first time point was
considered.
We calculated two main random effects meta-analyses, one for
episodic memory and one for pure and narrow-sense working
memory combined. A separate analysis of solely pure working
memory was not feasible due to the low number of available tasks
in that category. Homogeneity was tested using the Q-test for
between-study heterogeneity. We additionally report I2 as a mea-
surement of heterogeneity, which varies between 0 and 100%. I2 is a
measure of the percentage of total variation across studies due to
heterogeneity beyond chance, values over 50% indicate large het-
erogeneity [Ioannidis et al., 2007]. Potential publication bias was
assessed by visual inspection of funnel plots and by regression tests
for asymmetry. Furthermore, we included additional analyses that
feature unpublished data of three samples that performed episodic
and mainly pure working memory tasks to adjust for a potential
publication bias. We also excluded the three samples of the initial
study from the episodicmemory analysis to correct for thewinner’s
curse phenomenon. Additional analyses were calculated to deter-
mine ethnicity-specific estimates, but due to the low number of
studies involving non-Caucasian samples, it was not feasible to
separately conduct meta-analyses for these sub-samples. We also
assessed whether the different definitions of working memory
influenced the results of the meta-analyses.
Data analysis was done with R 2.14.0 [R Development Core
Team, 2011]. Estimation of Hedges d and r was done as recom-
mended by Nakagawa and Cuthill [2007]. The random effects
model was calculated using the metafor package [Viechtbauer,
2010] and the DerSimonian-Laird algorithm [DerSimonian and
Laird, 1986]. Reported P-values are two-tailed.
To illustrate the sample sizes needed to detect effects in the
range as estimated from our meta-analyses, we calculated power
analyses using the pwr package [Champely, 2009]. Alpha error rate
was set to 0.05 in the case of one independent test, which represents
the scenario of a single SNP replication (P< 0.05). In addition,
we simulated the GWAS scenario using a Bonferroni correction to
adjust for alpha-inflation in the case of multiple comparisons,
assuming 1" 106 independent tests per GWAS (P< 5" 10#8).
RESULTS
Search Results
Out of 47 hits that were yielded by the literature search with the
search terms ‘‘KIBRA’’ and ‘‘WWC1’’ (Supplementary Fig. 1), we
selected all 16 studies, which gave information on association
between KIBRA and a cognitive phenotype in the title or the
abstract. All 16 studies provide genotype information for SNP
rs17070175. The 31 not-further screened studies investigated mo-
lecular mechanism of KIBRA [Duning et al., 2008], KIBRA and
disease status without investigating cognitive phenotypes [Galecki
et al., 2010], or were review articles of KIBRA [Schneider et al.,
2010].
Excluded Studies and Samples
Out of the 16 studies that underwent the full text search, a total
of four studies had to be excluded completely with all provided
samples. Reasons for exclusion were as follows: Missing memory
phenotypes [Zhang et al., 2009], calculation of a C-dominant
genetic model (CC/CT vs. TT) [Hayashi et al., 2010], study
design (family-based association instead of a population-based
association) [Vassos et al., 2010], or missing statistics for effect
size calculation [Jacobsen et al., 2009]. One study provided infor-
mation on three independent samples out of which one had to be
excluded. For this specific sample (termedRS sample in the original
study) reported sample size information in combination with
health status was not traceable by means of the published data
[Burgess et al., 2011]. Follow-up measurements of the identical
task reported in two of the included studies were not considered
in the analysis [Kauppi et al., 2011; S!edille-Mostafaie et al.,
2011]. Sample and task information, estimation of effect size
and direction of effect for all excluded studies, samples and
follow-up measurements, as far as conclusive, are summarized in
Supplementary Table II.
Included Studies
A total of 12 studies comprising 17 independent samples met our
inclusion criteria (Table I). All studies were published between
2006 and 2011. Episodic memory tasks were performed in all
17 samples and for a total of 9 samples pure and narrow-sense
working memory tasks were reported. In the additional working
memory meta-analysis, we incorporated a total of 13 samples,
allowing also broad-sense working memory tasks in the analysis.
We also added three independent unpublished samples (Supple-
mentary Table III) taken from our ongoing studies, which all
provide episodic and mainly pure working memory tasks. Where
reported or calculable, P-values for HWE tests of rs17070145
were P> 0.03. For all but two samples [Burgess et al., 2011], we
estimated the effect sizes from a T-dominant model. Age range
varied from 18 to 100. Taking into account all studies that provided
information on themean age of their study populations, the over all
mean age was 64. Inclusion of the unpublished samples decreased
the mean age to 57. Apart from the two non-Caucasian samples,
a Japanese sample [Yasuda et al., 2010] and an African American
sample [Burgess et al., 2011], ethnic background of the study
populations was mainly Caucasian. Considered covariates varied
widely between studies. It is important to note that effect size
estimation from uncorrected values was not always possible be-
cause of missing values or confounding covariates.
Episodic Memory Random Effects Meta-Analysis
All published studies together comprise 17 samples that performed
episodicmemory tasks and overall sample size totaled toN¼ 8,909.
Effect size estimates per sample and the overall estimated effect size
for themainmeta-analysis are shown in Figure 1. I2 designates high
between-study heterogeneity (66.70%). We obtained a significant
result for the Q-test for between-studies heterogeneity (Q¼ 48.05,
df¼ 16, P¼ 5" 10#5), which requires the calculation of a random
effects meta-analysis. Neither funnel plot (Supplementary Fig. 2)
nor regression testing (t¼ 0.87, df¼ 15, P¼ 0.40) indicated a
significant publication bias. Estimated r for episodic memory is
0.068 (Z¼ 3.30, P¼ 0.001, 95% CI 0.028–0.109; corresponding
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d¼ 0.14), which results in 0.5% explained variance. Inclusion of
three independent unpublished samples (overall N¼ 10,263, 1,354
Caucasian subjects added) yielded an estimated rof 0.058 (Z¼ 3.15,
P¼ 0.002, 95% CI 0.022–0.093, I2¼ 63.52%). Exclusion of the
three samples of the initial study (overall N¼ 7.896, 1,013 Cauca-
sian subjects excluded) yielded an estimated r of 0.04 (Z¼ 2.19,
P¼ 0.03, 95% CI 0.004–0.076, I2¼ 49.37%). Exclusion of non-
Caucasian subjects (N¼ 411, African American and Japanese
samples) from the published data results in an estimated r of
0.067 (overall N¼ 8,498, Z¼ 3.28, P¼ 0.001, 95% CI 0.027–
0.107, I2¼ 64.07%).
Working Memory Random Effects Meta-Analysis
All published studies together comprise nine samples that per-
formed pure or narrow-sense working memory tasks and overall
sample size totaled to N¼ 4,696. Effect size estimates per sample
and the overall estimated effect size for the main meta-analysis
are shown in Figure 2. There is no hint for between-study hetero-
geneity (I2¼ 0%, Q¼ 7.02, df¼ 8, P¼ 0.53). Neither funnel plot
(Supplementary Fig. 3) nor regression testing (t¼#0.43, df¼ 7,
P¼ 0.68) revealed a significant publication bias. Estimated r for
pure and narrow-sense working memory together is 0.035
(Z¼ 2.36, P¼ 0.018, 95% CI 0.006–0.063; corresponding
d¼ 0.07) which results in 0.1% explained variance. Exclusion of
the pure working memory tasks (overall N¼ 4,272, Papassotiro-
poulos Swiss sample 2 excluded) yielded an estimated r of 0.037
(Z¼ 2.09, P¼ 0.04, 95% CI 0.002–0.073, I2¼ 12.48%). Inclusion
of three independent unpublished samples (overall N¼ 6,050;
1,354 Caucasian subjects added) yielded an estimated r of 0.040
(Z¼ 3.09, P¼ 0.002, 95% CI 0.015–0.065, I2¼ 0%). All three
independent unpublished samples provided mainly pure and
in one case an additional narrow-sense working memory task.
Exclusion of non-Caucasian subjects (N¼ 187, Japanese sample)
from the published data results in an estimated r of 0.030
(overall N¼ 4,509, Z¼ 2.02, P¼ 0.043, 95% CI 0.001–0.059,
I2¼ 0%). Combined analysis of pure, narrow-sense and broad-
sense working memory tasks from 13 published samples with an
overall sample size of N¼ 6,186 results in an estimated r of 0.039
(Z¼ 2.21, P¼ 0.027, 95% CI 0.004–0.073, I2¼ 35.11%).
We also performed a post hoc analysis combining all available
data (pure, narrow-sense andbroad-sensememory tasks, published
and unpublished data), since inclusion of the mainly pure working
memory tasks performed in the unpublished samples had the
same direction of effect as inclusion of samples which provide
broad-sense working memory tasks. This resulted in 16 indepen-
dent samples with an overall sample size of N¼ 7,540. Between-
study heterogeneity is present (I2¼ 23.36%), but not significant
(Q¼ 19.57, df¼ 15, P¼ 0.19). Estimated effect size for all 16
samples together results in r¼ 0.041 (Z¼ 2.90, P¼ 0.004, 95%
CI 0.013–0.069; corresponding d¼ 0.08), explaining 0.2%
variance.
Power and Sample Size Analysis
Detection of the estimated overall effect sizes with 80% probability
at an alpha error rate of 5% in the case of one single test would
require sample sizes of 2,000 subjects for an episodic memory
task and 5,000 subjects for working memory tasks, respectively
(Fig. 3A). In order to reach amultiple testing corrected significance
threshold assuming 1" 106 independent tests (P< 5" 10#8 as an
arbitrary, but often used significance threshold for GWAS) more
than 10,000 subjects are required to detect the effect on episodic
memory (Fig. 3B).
DISCUSSION
The present meta-analysis suggests a significant effect of KIBRA
SNP rs17070145 on episodic and working memory performance
and supports the importance of the GWAS approach for the
identification of molecules related to cognition in humans. The
meta-analysis-based effect size estimation for the association of
rs17070145 with episodic memory is substantially lower than
expected from the initial findings [Papassotiropoulos et al.,
2006], a phenomenon often referred to as ‘‘winner’s curse’’
[Kraft, 2008]. This phenomenon, that is overestimation of the
effect from the initial study, affects many research fields
[Ioannidis, 2008] including genetic association studies
[Ioannidis et al., 2001].
Wherever we are dealing with small sample sizes in relation to
the expected effect sizes and a stringent significance threshold,
an overestimation of the detected effect becomes very likely.
This phenomenon noticeably vanishes when samples with
adequate power are studied [Ioannidis, 2008]. A recent meta-
analysis ofGWAS investigating height reports that cumulated effect
sizes of 180 SNPs do not explain more than 17% of the observed
variance using a sample size of more than 180,000 subjects
[Lango Allen et al., 2010]. Single SNPs yielding the most sub-
stantial association signals with human height do not explain
more than 0.3–0.5% of the observed variance [Weedon et al.,
2007; Sanna et al., 2008; Visscher, 2008]. Thus, the estimated
explained variances by rs17070145 on episodic and working mem-
ory performance lie within the expected range for a quantitative
trait locus.
The expected moderate effect sizes in statistical genetics under-
line the importance of recruiting populations of adequate size in
order to be able to draw valid conclusions from genetic studies.
Thus it should be avoided to derive effect size estimates from the
initial study population. In contrast, the estimation of effect size
ranges should be based on sufficiently powered replication samples
and meta-analysis. Updating of effect-size estimations when more
data becomes available is a necessary means to obtainmore reliable
estimates. This course of action also counteracts the so-called
‘‘proteus phenomenon’’, that is early replications tend to be biased
towards the initial findings [Pfeiffer et al., 2011], which often
accompanies the ‘‘winner’s curse’’ phenomenon.
In the present meta-analysis, we included two additional sub-
analyses to account for the winner’s curse and publication bias
phenomena for the episodic memory task. To address the publica-
tion bias, we included data of three unpublished samples. In order
to adjust for the winner’s curse phenomenon, we excluded the
initial study samples. Both analyses yielded smaller effect-size
estimates for episodic memory, but the association remained
964 AMERICAN JOURNAL OF MEDICAL GENETICS PART B
significant. Since random effects meta-analysis adjusts for large
between study heterogeneity resulting in more conservative results
and larger confidence intervals, the estimated effect sizes can only
give hints for the range of the true effect sizes. Hence the provided
power plots depict ranges of effect sizes.
Generally, between-study heterogeneity tends to increase for
meta-analyses that comprise more samples [Ioannidis et al., 2007].
In the present meta-analysis, the between-study heterogeneity
differs for the episodic and working memory meta-analyses, being
higher for episodicmemory. This difference diminishes yet remains
present, if numbers of accounted studies becomemore equal. Study
heterogeneity, which hampers replication [Moonesinghe et al.,
2008], can be caused by a variety of factors, e.g. publication bias,
selective report of calculated statistical models, possible presence
of multiple functional variants in one gene, varying ethnic back-
ground including different linkage disequilibrium structure,
phenotype correlation, differences in phenotype definition and
experimental set up or gene-environment interactions. With the
available data it was not possible to discriminate, whether the
difference in homogeneity is a casual finding or has a systematic
underlying effect. The most notable reduction of between-study
heterogeneity could be achieved through the exclusion of the initial
study samples, which reflects the Winner’s Curse phenomenon.
Exclusion of non-Caucasian samples did not markedly influence
the level of heterogeneity. Given the amount of currently available
data, we set aside further stratification of the samples. With
more samples and larger sample sizes it might be feasible not
only to test for possible sources of heterogeneity by sample stratifi-
cation, but also to estimate sub-domain-specific effects as for
example visual versus verbal memory. However, quantifying
more general effects (e.g., episodic memory, working memory)
comes with the appealing advantage that a more generalized
interpretation of the underlying effect can be given.
The reported overall effect size estimates for KIBRA SNP
rs17070145may seemnegligible considering the explained variance
that can be attributed to this single variation. Yet it is important to
stress here that the objective target of the GWAS approach is not
to identify genetic variations that can explain the lion’s share
of phenotypic variation. Rather than that, this research approach
offers the possibility to capitalize on naturally occurring common
genetic variation to identify novel target molecules for a given
complex trait of interest. Hence GWAS comes with the inherent
FIG. 1. Forest plot for the episodic memory tasks. Weight represents the percentage given to the observed outcome during model fitting. Stars (*)
indicate samples with non-Caucasian ethnic background.
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strengths of a hypothesis-free, non-invasive and extremely flexible
approach that is suitable to study the biology of complex human
behavior. The scientific profit of GWAS is yielded by its potential to
provide valuable starting points for a variety of research disciplines,
which struggle together to elucidate the molecular underpinnings
of human cognition and heritable disease. In the case ofKIBRA, this
is illustrated, for example, by the studies of Makuch et al. [2011],
Corneveaux et al. [2010], and Burgess et al. [2011]. Makuch et al.
[2011] described the important role of KIBRA for learning and
memory in a knockout mouse model. Corneveaux et al. [2010]
combined three different lines of evidence to extend the association
of KIBRA from episodic memory performance to AD risk: Results
from a gene expression study in brain tissue of AD-affected
individuals, a brain imaging study (fluordesoxyglucose positron
emission tomography) and an association analysis with AD disease
status implicated a role for KIBRA in AD. In a meta-analytic
approach, Burgess et al. [2011] further supported the finding of
a potential effect on KIBRA on the risk to develop dementia. Thus
these studies broaden the initial finding of an association with
memory performance in healthy subjects to disease status. The
regulatory role of KIBRA in AMPAR membrane trafficking may
offer an explanation connecting the two findings, since it is known,
for example, that beta-amyloid induces disruption of the AMPA
signaling in AD [Shepherd and Huganir, 2007; Keifer and Zheng,
2010].
In summary, using a random effects meta-analytic approach,
we find a significant association between SNP rs17070145 with
episodic and working memory performance. KIBRA can be linked
to learning and memory, for example, through its interaction with
PKMzeta or its role in the regulation of AMPAR membrane
trafficking [B€uther et al., 2004; Schneider et al., 2010; Makuch
et al., 2011], which is a key mechanism underlying synaptic
plasticity. The estimated effect sizes that explain 0.1% of the
variance for working memory and 0.5% for episodic memory
are in the range of expected effect sizes for quantitative trait loci.
Taken together the example of KIBRA illustrates the power of the
GWAS approach to identify new targetmolecules related to human
memory and to contribute to the elucidation of the molecular
underpinnings of human cognition.
ACKNOWLEDGMENTS
This work was funded by the Swiss National Science Foundation
(Sinergia Grants CRSIK0_122691 andCRSI33_130080 toD.Q. and
FIG. 2. Forest plot for the pure and narrow-sense working memory tasks. Weight represents the percentage given to the observed outcome during
model fitting. Stars (*) indicate samples with non-Caucasian ethnic background.
966 AMERICAN JOURNAL OF MEDICAL GENETICS PART B
A.P.) and by the 7th framework programmeof the EuropeanUnion
(ADAMS Project, HEALTH-F4-2009-242257).
REFERENCES
Almeida OP, Schwab SG, Lautenschlager NT, Morar B, Greenop KR,
Flicker L,Wildenauer D. 2008. KIBRA genetic polymorphism influences
episodic memory in later life, but does not increase the risk of mild
cognitive impairment. J Cell Mol Med 12:1672–1676.
Ando J, Ono Y, Wright MJ. 2001. Genetic structure of spatial and verbal
working memory. Behav Genet 31:615–624.
Andreano JM, Cahill L. 2009. Sex influences on the neurobiology of
learning and memory. Learn Mem 16:248–266.
Bates TC, Price JF, Harris SE, Marioni RE, Fowkes FGR, Stewart MC,
Murray GD,Whalley LJ, Starr JM, Deary IJ. 2009. Association of KIBRA
and memory. Neurosci Lett 458:140–143.
Bird CM, Burgess N. 2008. The hippocampus and memory: Insights from
spatial processing. Nat Rev Neurosci 9:182–194.
Burgess JD, Pedraza O, Graff-Radford NR, Hirpa M, Zou F, Miles R,
Nguyen T, Li M, Lucas JA, Ivnik RJ, Crook J, Pankratz VS, Dickson DW,
Petersen RC, Younkin SG, Ertekin-Taner N. 2011. Association of com-
mon KIBRA variants with episodic memory and AD risk. Neurobiol
Aging 32:557.e1–557.e9.
B€uther K, Plaas C, Barnekow A, Kremerskothen J. 2004. KIBRA is a novel
substrate for protein kinase Czeta. Biochem Biophys Res Commun 317:
703–707.
CalkinsME, Tepper P, Gur RC, Ragland JD, Klei L,WienerHW, Richard J,
Savage RM, Allen TB, O’Jile J, Devlin B, Kwentus J, Aliyu MH, Bradford
LD, Edwards N, Lyons PD, Nimgaonkar VL, Santos AB, Go RCP, Gur
RE. 2010. Project among African-Americans to explore risks for schizo-
phrenia (PAARTNERS): Evidence for impairment and heritability of
neurocognitive functioning in families of schizophrenia patients. Am J
Psychiatry 167:459–472.
Champely S. 2009. pwr: Basic functions for power analysis. Available at.
http://cran.r-project.org/package¼pwr.
Corneveaux JJ, LiangWS,ReimanEM,Webster JA,MyersAJ, ZismannVL,
Joshipura KD, Pearson JV, Hu-Lince D, Craig DW, Coon KD, Dunckley
T, Bandy D, LeeW, Chen K, Beach TG,Mastroeni D, Grover A, Ravid R,
Sando SB, Aasly JO, Heun R, Jessen F, K€olsch H, Rogers J, Hutton ML,
Melquist S, Petersen RC, Alexander GE, Caselli RJ, Papassotiropoulos
A, Stephan DA, Huentelman MJ. 2010. Evidence for an association
between KIBRA and late-onset Alzheimer’s disease. Neurobiol Aging
31:901–909.
DerSimonianR, LairdN. 1986.Meta-analysis in clinical trials. ControlClin
Trials 7:177–188.
Drevets WC, Price JL, Furey ML. 2008. Brain structural and functional
abnormalities inmooddisorders: Implications forneurocircuitrymodels
of depression. Brain Struct Funct 213:93–118.
Duning K, Schurek E-M, Schl€uter M, Bayer M, Reinhardt H-C, Schwab A,
Schaefer L, Benzing T, Schermer B, SaleemMA, Huber TB, Bachmann S,
Kremerskothen J, Weide T, Pavenst€adt H. 2008. KIBRA modulates
directional migration of podocytes. J Am Soc Nephrol 19:1891–1903.
Finkel D, McGue M. 1998. Age differences in the nature and origin of
individual differences inmemory: A behavior genetic analysis. Int J Aging
Hum Dev 47:217–239.
Finkel D, Pedersen N, McGue M. 1995. Genetic influences on memory
performance in adulthood: Comparison of Minnesota and Swedish twin
data. Psychol Aging 10:437–446.
ForbesNF, Carrick LA,McIntoshAM, Lawrie SM. 2009.Workingmemory
in schizophrenia: A meta-analysis. Psychol Med 39:889–905.
Galecki P, Szemraj J, Florkowski A, TalarowskaM, BienkiewiczM, Galecka
E, Lewinski A. 2010. Single nucleotide polymorphism of the KIBRA gene
in recurrent depressive disorders. Neuro Endocrinol Lett 31:97–102.
FIG. 3. Power analysis for the expected range of effect sizes, which illustrates the relation of sample sizes and expected effect size to power.
A: Significance level is set toP¼ 0.05,whichwould besufficient in thescenario of testing asingle SNP.B: Significance level is set toP¼ 5" 10#8 to
correct for alpha-inflation in the case of 1" 106 independent tests to keep a maximum alpha error rate of 5%.
MILNIK ET AL. 967
Greenwood TA, Beeri MS, Schmeidler J, Valerio D, Ravent!os H, Mora-
Villalobos L, Camacho K, Carri!on-Baralt JR, Angelo G, Almasy L, Sano
M, Silverman JM. 2011. Heritability of cognitive functions in families of
successful cognitive aging probands from the Central Valley of Costa
Rica. J Alzheimers Dis 27:897–907.
Hayashi N, Kazui H, Kamino K, Tokunaga H, Takaya M, Yokokoji M,
Kimura R, Kito Y, Wada T, Nomura K, Sugiyama H, Yamamoto D,
Yoshida T, Currais A, Soriano S, Hamasaki T, Yamamoto M, Yasuda Y,
Hashimoto R, Tanimukai H, Tagami S, Okochi M, Tanaka T, Kudo T,
Morihara T, Takeda M. 2010. KIBRA genetic polymorphism influences
episodic memory in Alzheimer’s disease, but does not show association
with disease in a Japanese cohort. Dement Geriatr Cogn Disord 30:
302–308.
Hedges LV, Olkin I. 1985. Statistical methods for meta-analysis. Stat Med
20:825–840.
Herb A,WisdenW, CataniaMV,Mar!echal D, Dresse A, Seeburg PH. 1997.
Prominent dendritic localization in forebrain neurons of a novel mRNA
and its product, dendrin. Mol Cell Neurosci 8:367–374.
Ioannidis JPA. 2008. Why most discovered true associations are inflated.
Epidemiology 19:640–648.
Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. 2001.
Replication validity of genetic association studies.NatGenet 29:306–309.
Ioannidis JPA,PatsopoulosNA,EvangelouE. 2007.Heterogeneity inmeta-
analyses of genome-wide association investigations. PLoS ONE 2:e841.
Jacobsen LK, PicciottoMR, Heath CJ, MenclWE, Gelernter J. 2009. Allelic
variation of calsyntenin 2 (CLSTN2) modulates the impact of develop-
mental tobacco smoke exposure onmnemonic processing in adolescents.
Biol Psychiatry 65:671–679.
Johannsen S, Duning K, Pavenst€adt H, Kremerskothen J, Boeckers TM.
2008. Temporal-spatial expression and novel biochemical properties of
the memory-related protein KIBRA. Neuroscience 155:1165–1173.
Johansson B,Whitfield K, PedersenNL,Hofer SM, Ahern F,McClearnGE.
1999. Origins of individual differences in episodic memory in the oldest-
old: A population-based study of identical and same-sex fraternal twins
aged 80 and older. J Gerontol B Psychol Sci Soc Sci 54:173–179.
Kauppi K, Nilsson L-G, Adolfsson R, Eriksson E, Nyberg L. 2011. KIBRA
polymorphism is related to enhancedmemory and elevatedhippocampal
processing. J Neurosci 31:14218–14222.
Keifer J, Zheng Z. 2010. AMPA receptor trafficking and learning. Eur J
Neurosci 32:269–277.
Kraft P. 2008. Curses-winner’s and otherwise-in genetic epidemiology.
Epidemiology 19:649–651.
Kremerskothen J, PlaasC, B€utherK, Finger I, Veltel S,Matanis T, LiedtkeT,
Barnekow A. 2003. Characterization of KIBRA, a novel WW domain-
containing protein. Biochem Biophys Res Commun 300:862–867.
Kremerskothen J, Kindler S, Finger I, Veltel S, Barnekow A. 2006. Postsyn-
aptic recruitment of dendrin depends onbothdendriticmRNA transport
and synaptic anchoring. J Neurochem 96:1659–1666.
LangoAllenH, Estrada K, Lettre G, Berndt SI,WeedonMN, Rivadeneira F,
Willer CJ, Jackson AU, Vedantam S, Raychaudhuri S, Ferreira T, Wood
AR,Weyant RJ, Segr#e AV, Speliotes EK,Wheeler E, SoranzoN, Park J-H,
Yang J, Gudbjartsson D, Heard-Costa NL, Randall JC, Qi L, Vernon
Smith A, M€agi R, Pastinen T, Liang L, Heid IM, Luan J, Thorleifsson G,
Winkler TW, Goddard ME, Sin Lo K, Palmer C, Workalemahu T,
Aulchenko YS, Johansson A, Zillikens MC, Feitosa MF, Esko T, Johnson
T, Ketkar S, Kraft P, Mangino M, Prokopenko I, Absher D, Albrecht E,
Ernst F, Glazer NL, Hayward C, Hottenga J-J, Jacobs KB, Knowles JW,
Kutalik Z, Monda KL, Polasek O, Preuss M, Rayner NW, Robertson NR,
Steinthorsdottir V, Tyrer JP, Voight BF, Wiklund F, Xu J, Zhao JH,
Nyholt DR, Pellikka N, PerolaM, Perry JRB, Surakka I, TammesooM-L,
Altmaier EL, Amin N, Aspelund T, Bhangale T, Boucher G, Chasman
DI, Chen C, Coin L, Cooper MN, Dixon AL, Gibson Q, Grundberg E,
Hao K, Juhani Junttila M, Kaplan LM, Kettunen J, K€onig IR, Kwan T,
Lawrence RW, Levinson DF, Lorentzon M, McKnight B, Morris
AP, M€uller M, Suh Ngwa J, Purcell S, Rafelt S, et al. 2010. Hundreds
of variants clustered in genomic loci and biological pathways affect
human height. Nature 467:832–838.
Makuch L, Volk L, Anggono V, Johnson RC, Yu Y, Duning K, Kremer-
skothen J, Xia J, Takamiya K, Huganir RL. 2011. Regulation of AMPA
receptor function by the human memory-associated gene KIBRA. Neu-
ron 71:1022–1029.
Marazziti D, Consoli G, Picchetti M, Carlini M, Faravelli L. 2010.
Cognitive impairment in major depression. Eur J Pharmacol 626:
83–86.
Mesholam-Gately RI, GiulianoAJ, Goff KP, Faraone SV, Seidman LJ. 2009.
Neurocognition in first-episode schizophrenia: A meta-analytic review.
Neuropsychology 23:315–336.
Moonesinghe R, Khoury MJ, Liu T, Ioannidis JPA. 2008. Required sample
size and nonreplicability thresholds for heterogeneous genetic associa-
tions. Proc Natl Acad Sci USA 105:617–622.
Nacmias B, Bessi V, Bagnoli S, Tedde A, Cellini E, Piccini C, Sorbi S,
Bracco L. 2008. KIBRA gene variants are associated with episodic
memory performance in subjective memory complaints. Neurosci Lett
436:145–147.
Nakagawa S, Cuthill IC. 2007. Effect size, confidence interval and statistical
significance: A practical guide for biologists. Biol Rev Camb Philos Soc
82:591–605.
Need AC, Attix DK, McEvoy JM, Cirulli ET, Linney KN, Wagoner AP,
Gumbs CE, Giegling I,M€oller H-J, Francks C,Muglia P, Roses A, Gibson
G,WealeME,RujescuD,GoldsteinDB. 2008. Failure to replicate effect of
Kibra on human memory in two large cohorts of European origin. Am J
Med Genet B Neuropsychiatr Genet 147B:667–668.
Papassotiropoulos A, Stephan DA, Huentelman MJ, Hoerndli FJ, Craig
DW, Pearson JV, Huynh K-D, Brunner F, Corneveaux J, Osborne D,
Wollmer MA, Aerni A, Coluccia D, H€anggi J, Mondadori CRA, Buch-
mann A, Reiman EM, Caselli RJ, Henke K, de Quervain DJ-F. 2006.
CommonKibra alleles are associated with humanmemory performance.
Science 314:475–478.
ParkDC, LautenschlagerG,HeddenT,DavidsonNS, SmithAD, Smith PK.
2002. Models of visuospatial and verbal memory across the adult life
span. Psychol Aging 17:299–320.
Pfeiffer T, Bertram L, Ioannidis JPA. 2011. Quantifying selective reporting
and the proteus phenomenon for multiple datasets with similar bias.
PLoS ONE 6:e18362.
PreuschhofC,HeekerenHR,Li S-C, SanderT,LindenbergerU,B€ackmanL.
2010. KIBRA and CLSTN2 polymorphisms exert interactive effects on
human episodic memory. Neuropsychologia 48:402–408.
R Development Core Team. 2011. R: A language and environment for
statistical computing. Available at. http://www.r-project.org/.
RanganathC. 2010. A unified framework for the functional organization of
the medial temporal lobes and the phenomenology of episodic memory.
Hippocampus 20:1263–1290.
Read S, Pedersen NL, Gatz M, Berg S, Vuoksimaa E, Malmberg B,
Johansson B, McClearn GE. 2006. Sex differences after all those years?
Heritability of cognitive abilities in old age. J Gerontol B Psychol Sci Soc
Sci 61:137–143.
Rodr!ıguez-Rodr!ıguez E, Infante J, Llorca J, Mateo I, S!anchez-Quintana C,
Garc!ıa-Gorostiaga I, S!anchez-Juan P, Berciano J, Combarros O. 2009.
Age-dependent association of KIBRA genetic variation and Alzheimer’s
disease risk. Neurobiol Aging 30:322–324.
968 AMERICAN JOURNAL OF MEDICAL GENETICS PART B
Samuelson KW. 2011. Post-traumatic stress disorder and declarative
memory functioning: A review. Dialogues Clin Neurosci 13:346–351.
Sanna S, Jackson AU, Nagaraja R, Willer CJ, Chen W-M, Bonnycastle LL,
Shen H, Timpson N, Lettre G, Usala G, Chines PS, Stringham HM,
Scott LJ, Dei M, Lai S, Albai G, Crisponi L, Naitza S, Doheny KF, Pugh
EW,Ben-ShlomoY,EbrahimS,LawlorDA,BergmanRN,WatanabeRM,
Uda M, Tuomilehto J, Coresh J, Hirschhorn JN, Shuldiner AR, Schles-
singer D, Collins FS, Davey Smith G, Boerwinkle E, Cao A, Boehnke M,
Abecasis GR, Mohlke KL. 2008. Common variants in the GDF5-UQCC
region are associated with variation in human height. Nat Genet 40:
198–203.
Schaper K, Kolsch H, Popp J, Wagner M, Jessen F. 2008. KIBRA gene
variants are associated with episodic memory in healthy elderly. Neuro-
biol Aging 29:1123–1125.
Schneider A, Huentelman MJ, Kremerskothen J, Duning K, Spoelgen R,
Nikolich K. 2010. KIBRA: A new gateway to learning and memory?
Front Aging Neurosci 2:2–4.
S!edille-Mostafaie N, Sebesta C, Huber KR, Zehetmayer S, Jungwirth S,
TraglKH,FischerP,KruglugerW.2011.The role ofmemory-related gene
polymorphisms, KIBRA and CLSTN2, on replicate memory assessment
in the elderly. J Neural Transm 119:77–80.
Shepherd JD, Huganir RL. 2007. The cell biology of synaptic plasticity:
AMPA receptor trafficking. Annu Rev Cell Dev Biol 23:613–643.
Van Snellenberg JX. 2009. Working memory and long-term memory
deficits in schizophrenia: Is there a common substrate? Psychiatry Res
174:89–96.
Vassos E, Bramon E, Picchioni M, Walshe M, Filbey FM, Kravariti
E, McDonald C, Murray RM, Collier DA, Toulopoulou T. 2010.
Evidence of association of KIBRA genotype with episodic memory
in families of psychotic patients and controls. J Psychiatr Res 44:
795–798.
Viechtbauer MW. 2010. Conducting meta-analyses in R with the metafor
package. J Stat Softw 36:1–48.
Visscher PM. 2008. Sizing up human height variation. Nat Genet 40:
489–490.
VolkHE,McDermottKB,RoedigerHL,ToddRD. 2006.Genetic influences
on free and cued recall in long-termmemory tasks. Twin ResHumGenet
9:623–631.
Weedon MN, Lettre G, Freathy RM, Lindgren CM, Voight BF, Perry JRB,
Elliott KS, Hackett R, Guiducci C, Shields B, Zeggini E, Lango H,
Lyssenko V, Timpson NJ, Burtt NP, Rayner NW, Saxena R, Ardlie K,
Tobias JH, Ness AR, Ring SM, Palmer CNA, Morris AD, Peltonen L,
Salomaa V, Davey Smith G, Groop LC, Hattersley AT, McCarthy MI,
Hirschhorn JN, Frayling TM. 2007. A common variant of HMGA2 is
associatedwith adult and childhoodheight in the general population.Nat
Genet 39:1245–1250.
Wersching H, Guske K, Hasenkamp S, Hagedorn C, Schiwek S, Jansen S,
Witte V, Wellmann J, Lohmann H, Duning K, Kremerskothen J, Knecht
S, Brand E, Floel A. 2011. Impact of common KIBRA allele on human
cognitive functions. Neuropsychopharmacology 36:1296–1304.
Wilson RS, Barral S, Lee JH, Leurgans SE, Foroud TM, Sweet RA, Graff-
Radford N, Bird TD, Mayeux R, Bennett DA. 2011. Heritability of
different forms of memory in the Late Onset Alzheimer’s Disease Family
Study. J Alzheimers Dis 23:249–255.
Yasuda Y, Hashimoto R, Ohi K, Fukumoto M, Takamura H, Iike N,
YoshidaT,HayashiN,TakahashiH,YamamoriH,MoriharaT,TagamiS,
Okochi M, Tanaka T, Kudo T, Kamino K, Ishii R, Iwase M, Kazui H,
TakedaM. 2010. Association study of KIBRA gene with memory perfor-
mance in a Japanese population. Biol Psychiatry 11:852–857.
Zhang H, Kranzler HR, Poling J, Gruen JR, Gelernter J. 2009. Cognitive
flexibility is associated with KIBRA variant and modulated by recent
tobacco use. Neuropsychopharmacology 34:2508–2516.
MILNIK ET AL. 969
Original Research Papers 
 40 
4.2 Substantial SNP-based heritability estimates for working memory 
performance 
  
OPEN
ORIGINAL ARTICLE
Substantial SNP-based heritability estimates for working
memory performance
C Vogler1,2,3,4,6, L Gschwind1,5,6, D Coynel5, V Freytag1, A Milnik1,2, T Egli1, A Heck1,2,3, DJ-F de Quervain2,3,5 and
A Papassotiropoulos1,2,3,4
Working memory (WM) is an important endophenotype in neuropsychiatric research and its use in genetic association studies is
thought to be a promising approach to increase our understanding of psychiatric disease. As for any genetically complex trait,
demonstration of sufﬁcient heritability within the speciﬁc study context is a prerequisite for conducting genetic studies of that trait.
Recently developed methods allow estimating trait heritability using sets of common genetic markers from genome-wide
association study (GWAS) data in samples of unrelated individuals. Here we present single-nucleotide polymorphism (SNP)-based
heritability estimates (h2SNP) for a WM phenotype. A Caucasian sample comprising a total of N= 2298 healthy and young individuals
was subjected to an N-back WM task. We calculated the genetic relationship between all individuals on the basis of genome-wide
SNP data and performed restricted maximum likelihood analyses for variance component estimation to derive the h2SNP estimates.
Heritability estimates for three 2-back derived WM performance measures based on all autosomal chromosomes ranged between
31 and 41%, indicating a substantial SNP-based heritability for WM traits. These results indicate that common genetic factors
account for a prominent part of the phenotypic variation in WM performance. Hence, the application of GWAS on WM phenotypes
is a valid method to identify the molecular underpinnings of WM.
Translational Psychiatry (2014) 4, e438; doi:10.1038/tp.2014.81; published online 9 September 2014
INTRODUCTION
Working memory (WM) has a pivotal role in human cognition and
cognitive performance, allowing the integration of information
from instantly perceived stimuli, long-term-memory and thought-
processes. A wide variety of psychological testing procedures have
been developed to render WM performance quantiﬁable.1–4
Assessment of WM performance along with brain imaging
techniques have been used to elucidate and delimit its different
components, aiming at a more circumscribed understanding of
the neuronal processes at the basis of WM.5 The integration of
extensive research on WM yields a common consensus that it
constitutes a complex trait and that the buffer size for the
transiently stored content varies interindividually, which is partly
due to genetic factors. WM is an important endophenotype in
neuropsychiatric research and its use in genetic association
studies is thought to be a promising approach to increase our
understanding of psychiatric disease.6–11 Namely, two recent
studies have corroborated the genetic link between schizophrenia
and WM, demonstrating the validity of this endophenotype for
schizophrenia research: Stefansson et al.12 report that control
subjects carrying Copy Number Variants, which predispose to
schizophrenia and autism, perform at a level that is in between
patients and population controls in cognitive tasks including a
spatial WM test. A genome-wide gene set enrichment study
conducted by our group, identiﬁed a set of voltage-gated cation
channel activity genes that were robustly linked to performance in
WM tasks in healthy individuals and also to risk for schizophrenia
in a large case–control sample.13 Both these studies suggest that
the ﬁndings of cognitive deﬁcits are translatable between healthy
subjects and cohorts of psychiatric patients. Improving our
understanding of the molecular basis of this endophenotype
might be key for future drug discovery and treatment options in
psychiatry.14,15 As for any genetically complex trait, demonstration
of sufﬁcient heritability within the speciﬁc study context is a
prerequisite for conducting genetic studies of that trait. Herit-
ability is a concept that summarizes how much of the phenotypic
variation in a given trait is attributable to heritable factors, the
majority of them being genetic. Since inter-individual trait
differences attributable to genetic variability are a prerequisite
for quantitative trait loci mapping, estimation of trait heritability is
important to demonstrate the validity of a quantitative trait loci
study of a given trait. Conventionally, heritability estimates in
humans are derived from phenotypic data by comparing
correlations between relatives, where the extent of genetic
relatedness is derived from the degree of relationship. Results
from previous twin and family studies that used a variety of tasks
to measure WM performance have shown heritability estimates
ranging between 15 and 72%.16–19 Recently developed methods
propose inferring genetic identity from high-throughput SNP data
and correlating these estimates with phenotypic resemblance
among unrelated individuals.20,21 This allows the estimation of an
SNP-based heritability measure (h2SNP) for any speciﬁc genome-
wide association study data set. Importantly, the h2SNP value
quantiﬁes the amount of phenotypic variation that can be
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explained by the common SNPs represented in genome-wide
association study data sets. Of note, h2SNP hereby represents a
lower bound heritability estimate, because causal variants that are
neither genotyped nor tagged by the used set of markers are
completely disregarded. In the present study we show that a
substantial part of phenotypic variance of WM performance can
be explained by using the common marker set represented on the
Affymetrix 6.0 Human SNP array to estimate h2SNP values for N-
back-derived WM phenotypes.
MATERIALS AND METHODS
Ethics statement
The experiments were approved by the ethics committee of the Cantons of
Basel-City and Basel-Country. Written informed consent was obtained from
all subjects before participation.
Participants and genotyping procedure
A sample of 2703 young healthy Swiss individuals (1721 females, 982
males; mean age: 22.5 years; median age: 22 years; range: 18–38 years) was
assessed for WM performance using an N-back task. Saliva samples were
obtained from each study participant, using an Oragene DNA Self-
Collection Kit (DNA Genotek, Ottawa, Ontario, Canada). DNA was extracted
from saliva using standard protocols. All subjects were individually
genotyped using the Affymetrix Human SNP assay 6.0 according to the
manufacturer’s recommendation.
N-back task
All subjects completed the 0-back and 2-back version of the N-back task,
after they were instructed and trained on the task. The 0-back condition
served as a non-memory-guided control condition, measuring general
attention, concentration and reaction time. The N-back task was presented
on a computer screen and consisted of 12 blocks (six 0-back and six 2-back
blocks). Per block, 14 stimuli consisting of 3 targets and 11 non-targets,
were presented in a randomized order. Each stimulus was presented for
500ms, followed by a black screen for 1500ms. For each stimulus
participants had to indicate as fast as possible whether it was a target or a
non-target by pressing the corresponding button. At the beginning of
each block the instruction was shown for 5 s. There was a 20 s break after
every second block. The two blocks between the breaks consisted of a 0-
back and a 2-back block, which were presented in a randomized order.
Each block lasted for 33 s. The N-back task had a total duration of roughly
10min, including instructions presented at the beginning of the task.
Performance in the 0-back and the 2-back tasks was assessed by the mean
correct response accuracy. The difference in mean accuracy between 2-
back and the 0-back condition served as main phenotype (2-back mean
accuracy attention corrected: 2-back− 0-back). We also tested the
uncorrected 2-back mean accuracy and the d-prime for the 2-back
condition. The d-prime was calculated according to the following formula:
d‘ ¼ Probitðhit rateÞ - Probitðfalse alarm rateÞ
The maximal number of hits (that is, correct responses to targets) was
N=36 and the maximal number of false alarms (that is, incorrect responses
to non-targets) was N= 132. To allow for a probit-transformation, the hit
and false-alarm-rates of 0 or 1 had to be avoided by replacing these
extreme values, which was done as follows: 100% of hits were set to
1− 1/36 and 0% were set to 1/36. Accordingly, 100% of false alarms were
set to 1− 1/132 and 0% of false alarms were set to 1/132.22 In addition, we
also estimated h2SNP for the mean reaction time of the 2-back task (2-back
mean reaction time). See Table 1 for descriptive statistics of uncorrected
task performance measures.
Genotypic outlier analysis
We identiﬁed and subsequently excluded subjects with technical biases or
non-Caucasian ancestry. A Bayesian clustering algorithm was applied to
genome-wide summary statistics to identify and exclude samples affected
by a potential technical bias. Brieﬂy, considering a combination of genome-
wide call rate and heterozygosity rate, the algorithm infers each sample's
posterior probability to belong to the outliers' class, as extreme values for
these summary statistics may be indicative of a genotyping bias. Similarly,
the Bayesian clustering algorithm was applied on the coordinates of the
subjects on the ﬁrst two PCA components inferred from HapMap data using
the YRI, CEU and CHB-JPT populations. Thus, samples of non-Caucasian
ancestry were identiﬁed and removed, excluding N=272 individuals.23
Phenotypic and genetic quality controls
To adjust for sex and age, all N-back derived performance measurements
(accuracy and reaction time) entered a linear model and residuals were
extracted, which were used for all further calculations. As the presence of
outliers in the phenotypic data can affect heritability estimation for
complex traits,24 all subjects whose performance measurements in any of
the four N-back performance measurements differed more than 3.5
standard deviations from the sample mean were excluded (Nexcluded = 40).
Due to this procedure, the exact same number of subjects was included
in all subsequent analyses for all investigated phenotypes.
The genotype data set was ﬁltered (MAF⩾ 0.01; HWE pFisher⩾ 0.001; per
SNP call rate⩾ 95%; per individual call rate⩾ 95%) to obtain a set of
702’744 autosomal and 27’265 X-chromosomal SNPs for further analysis.
Estimation of the pairwise genetic similarity using all autosomal markers
and subsequently removing one of each pairs showing genetic relatedness
40.025 (~ second-degree cousins) led to the exclusion of N=93 subjects,
yielding a sample size of N=2298 for h2SNP estimation.
h2SNP Estimation
To obtain the genome-wide heritability estimates h2SNP, we calculated the
genetic relationship between all individuals on the basis of the autosomal
SNP data and performed restricted maximum likelihood analyses for
variance component estimation using the GCTA software package.20 In a
second step, h2SNP estimates were calculated for all chromosomes
separately including the X-chromosome. The genetic relationship matrix
for the X-chromosome was obtained using the designated option in the
GCTA toolset.
RESULTS
Heritability estimates for the three 2-back derived WM perfor-
mance measures on the basis of autosomal chromosomes ranged
between 31 and 41%, indicating substantial SNP-based heritabil-
ities (Figure 1). The proportion of phenotypic variance explained
by all autosomal SNPs for difference in response accuracy
between the 2-back and the 0-back condition was 41%
(s.e. = 0.139; P-value = 0.0008). h2SNP for the mean response
accuracy in the 2-back alone (that is, without correction for
0-back performance) and the false-response corrected d-prime
condition were 31% with s.e. = 0.138; P-value = 0.006 and s.
e. = 0.140; P-value = 0.01, respectively. Due to several reports
linking processing speed to WM-related cognitive abilities,25,26
we also investigated heritability of the mean reaction time in
the 2-back condition (h2SNP: 24%; s.e. = 0.142; P-value = 0.04). A
Table 1. Descriptive statistics of task performance measures
2-Back− 0-back 2-Back d-Prime MRT 2-back
Total (N= 2298) −0.077 (0.07) 0.891 (0.07) 2.436 (0.84) 558.224 (128.12)
Females (N= 1471) − 0.075 (0.07) 0.895 (0.07) 2.485 (0.83) 568.890 (131.09)
Males (N= 827) − 0.082 (0.07) 0.885 (0.07) 2.347 (0.85) 539.252 (120.43)
Abbreviations: MRT, mean reaction time; WM, working memory. Performance metrics for WM (N-back derived) and RT in milliseconds: mean (s.d.).
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descriptive analysis of correlations between phenotypes shows
strong intercorrelations between the three accuracy-related 2-
back WM phenotypes (r240.65), whereas correlation coefﬁcients
between the mean reaction time in the 2-back condition and the
WM phenotypes are negligible (r2o0.01) by means of shared
phenotypic variance (Table 2).
Chromosomewise h2SNP estimates
In a further step, we partitioned heritability into contributions
from single chromosomes, including the X-chromosome. Figure 2
shows the h2SNP values per chromosome, presenting an approx-
imation to the amount of phenotypic variance explained by the
single chromosomes. For each phenotype, we derived a vector
containing h2SNP estimates per chromosome. To investigate
whether the correlational pattern of the phenotypes is reﬂected
also in a similar chromosomal heritability proﬁle, we calculated the
Pearson’s correlation coefﬁcients for these vectors. The highly
correlated WM phenotypes show a similar proﬁle for the
chromosomewise h2SNP estimates. Regarding the single chromo-
some h2SNP values for the mean reaction time in the 2-back
condition, we observe a different distribution of h2SNP estimates per
chromosome. Table 3 depicts the descriptive Pearson’s correlation
coefﬁcients between the chromosomewise h2SNP estimates for all
phenotypes. We also investigated whether the chromosomal
length and the number of SNPs are correlated with the
phenotypic variance that each chromosome explains. We
observed signiﬁcant correlations (Pearson’s r in the range between
0.53 and 0.68) for the WM phenotypes with the chromosomal
length and number of SNPs, whereas no signiﬁcant correlation
was observed for the mean reaction time of the 2-back task (See
Table 4).
DISCUSSION
The present data demonstrate that a substantial proportion of
variance in WM performance is captured by common genome-
wide association study SNPs in a sample of healthy young
unrelated individuals. The h2SNP estimates for the N-back-derived
WM phenotypes range from 31 to 41% with a mean standard error
of 0.14. Thus, the h2SNP estimates are consistent with the previously
reported heritability for WM on the basis of twin-studies.27 Taken
together, these ﬁndings add further support for the hypothesis
that WM is a highly heritable trait. The chromosomal partitioning
analysis (Figure 2), which depicts h2SNP estimates for all chromo-
somes analyzed individually, provides a clear hint for the
pronounced polygenicity of the investigated WM phenotype. This
ﬁnding is in line with the previously reported ubiquitious
polygenicity of human complex traits.28 The amount of genetic
variation that explains the variance of WM performance is
proportional to the chromosomal length and the number of
investigated SNPs per chromosome (see Table 4). The correlational
pattern for the investigated phenotypes (see Table 2) indicates
that the WM performance measures and the mean reaction time
are independent behavioral metrics. The h2SNP estimate based on
genome-wide data (see Figure 1) are lower for the mean reaction
time and the h2SNP estimates per chromosome also show a
different distribution compared with the WM performance derived
estimates (see Figure 2). Furthermore, although there is an
observable trend for the proportionality of h2SNP estimates with
chromosomal length, the correlation fails to reach statistical
signiﬁcance (see Table 2), which may be due to a lower overall
heritability of this trait. Hence, we conclude that the WM
performance measured with the 2-back task is independent of
the mean response time under the cognitive load of performing
the 2-back test.
Of note, the heritability estimation for complex traits using
genome-wide data sets is rather a complement than a substitution
to studies on twin- and family-based heritability. Marker-based
heritability estimation represents a lower bound for the true trait
heritability as it relies only on the effects of common variants
assuming an additive variance model. On one hand, the
investigation of large pools of unrelated individuals allows to
assess heritability without the undermining effects due to shared
environment or familiality. Yet, on the other hand, it will not take
the potential effects of rare variants into account. The SNP-based
heritability estimates for WM suggest that a large share of
phenotypic variance can be explained by common SNPs rendering
well-powered genome-wide association study data sets a promis-
ing tool to discover molecular players that act in concert to form
this complex trait. It has been repeatedly shown that familial risk
for psychiatric diseases like schizophrenia is often accompanied by
reduced cognitive abilities.29–31 Results from a long-term study
suggest that people who reported psychotic-like experiences in
late adulthood performed poorer in cognitive tasks during
childhood and adolescence.32 In a recent twin study investigating
healthy twins, Goldberg et al.6 report that the phenotypic
correlation between intelligence quotient and WM can be almost
entirely attributed to shared genetic variance. In an effort to
investigate dimensions of observable behavior and neurobiologi-
cal measures that can be used to classify psychopathology, the
National Institute of Mental Health established the Research
Domain Criteria project. The N-back task used in the present study
Figure 1. h2SNP estimates for 2-back derived WM measures in percent
for a total of N= 2298. The error bars represent standard errors. 2-
Back mean accuracy attention corrected (corr.) h2SNP 41%, s.e. 14%,
P-value= 0.0008; 2-back mean accuracy h2SNP 31%, s.e. 14%, P-
value= 0.006; 2-back d-prime h2SNP 31%, s.e. 14%, P-value= 0.01;
2-back mean reaction time h2SNP 24%, s.e. 14%, P-value= 0.04. SNP,
single-nucleotide polymorphism; WM, working memory.
Table 2. Correlation of phenotypes
2-Back− 0-back 2-Back d-Prime
2-Back− 0-back
2-Back 0.91***
d-Prime 0.83*** 0.94***
MRT 2-back − 0.08*** 0.01 0.06**
Abbreviation: MRT, mean reaction time. Pearson’s correlation coefﬁcients,
df= 2296; *Po0.05, **Po0.005, ***Po0.0005.
h2SNP estimation for WM
C Vogler et al
3
© 2014 Macmillan Publishers Limited Translational Psychiatry (2014), 1 – 5
is deemed appropriate to measure the sub-constructs of WM of
active maintenance, limited capacity and with some, albeit not
deﬁnitive evidence, for ﬂexible updating according to the
Research Domain Criteria project. Given the implication of
cognitive and especially WM deﬁcits in schizophrenia and other
psychiatric disorders, the genetically guided decomposition of
WM-related molecular pathways might pave the way for a better
understanding of the genetic architecture implicated in these
mental disorders.
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Abstract!!
DNA!methylation!represents!an!important!link!between!structural!genetic!variation!and!
complex!phenotypes.!The!study!of!genomeMwide!CpG!methylation!and!its!relation!to!traits!
relevant!to!psychiatry!has!become!increasingly!important.!Here,!we!analyzed!quality!metrics!of!
396’833!CpG!sites!in!a!population!of!568!mentally!healthy!young!adults.!For!25!%!of!all!CpGs!we!
observed!medium!to!large!common!epigenetic!variation.!These!CpGs!were!overrepresented!in!
open!sea!and!shore!regions,!as!well!as!in!intergenic!regions.!Furthermore,!methylation!
quantitative!trait!loci!(meQTLs)!were!strongly!enriched!for!the!mostMvariable!CpGs.!This!
suggests!that!a!significant!proportion!of!common!DNA!methylation!is!at!least!partially!
genetically!driven!and!may!be!observed!similarly!across!tissues.!These!findings!are!of!particular!
relevance!for!studies!of!complex!neuropsychiatric!traits,!which!often!rely!on!proxy!tissues.!
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Text!
Phenotypic!differences!between!individuals!are!only!partially!explained!by!genetic!differences.!
Additional!sources!of!variation,!including!epigenetic!regulation,!are!also!centrally!involved!in!
trait!variability!and!disease!etiology!(1).!Of!the!various!epigenetic!mechanisms,!DNA!
methylation!is!being!studied!most!extensively,!because!the!available!technology!allows!for!the!
investigation!of!methylation!patterns!at!both!high!resolution!and!–throughput!(2).!DNA!
methylation!represents!an!important!connection!between!structural!genetic!variation!and!
complex!phenotypes!(3),!a!link!that!can!be!investigated!by!epigenomeMwide!association!studies!
(EWAS)!(4;!5).!However,!EWAS!are!challenged!by!the!high!complexity!of!the!methylation!signal,!
which!displays!variability!related!to!such!factors!as!the!population!under!study,!tissue!and!
temporal!dynamics.!Further!such!signals!consist!of!varying!amounts!of!measurement!error!and!
systematic!variance!of!no!interest!(like!technical!artifacts)!(6–9).!!
In!a!population!under!study,!replication!analyses!allow!to!estimate!a!trait’s!naturally!
occurring!variation!(i.e.,!signals’!variance!exceeding!the!technical!variance!and!random!noise!
(10)).!Within!the!scope!of!highMdensity!biological!data,!replication!analyses!can!be!done!on!
different!levels.!Typically,!analysis!of!technical!replicates!for!CpG!methylation!data!is!done!on!a!
methylomeMwide!level!by!comparing!overall!methylation!profiles!(11).!On!a!methylomeMwide!
level,!high!reproducibility!within!and!between!technologies!has!been!repeatedly!shown!(2;!12).!
However,!association!studies!such!as!EWAS!are!done!on!singleMCpG!level.!Therefore,!we!focused!
herein!on!the!assessment!of!epigenetic!variation!in!each!singleMCpG!by!evaluating!the!replication!
analysis!on!singleMCpG!level.!
Owing!to!the!complexity!of!the!CpG!methylation!signal!and!to!the!underlying!dynamic!
regulation!mechanisms,!results!from!methylation!association!studies!are!challenged!by!
interpretational!difficulties,!especially!in!crossMsectional!designs!(13;!14).!With!respect!to!that,!
the!identification!of!mostMvariable!and!reproducible!CpGs!in!a!sample!of!healthy!young!adults!
may!serve!as!a!baseline!for!the!assessment!of!common!epigenetic!variation!and!as!a!guiding!
reference!for!other!studies.!Importantly,!such!a!reference!contributes!to!the!identification!of!
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CpGs!that!show!common!epigenetic!variation!as!opposed!to!CpGs!for!which!epigenetic!
differences!emerge!in!the!course!of!disease!(15).!!
Here!we!performed!comprehensive!reliability!analyses!of!the!CpG!methylation!signal!by!
utilizing!the!widely!used!Illumina!Infinium!Human!Methylation!450K!array!in!a!large!sample!of!
mentally!healthy!young!adults.!We!also!conducted!a!series!of!association!studies!with!CpG!
methylation!as!the!dependent!variable!for!validation!purpose.!As!expected,!technical!replication!
analyses!on!a!methylomeMwide!level!showed!high!reproducibility!for!human!DNA!derived!from!
blood.!On!singleMCpG!level!a!considerable!part!of!CpGs!showed!naturally!occurring!variation!(see!
supplementary!table!1).!The!mostMvariable!CpGs!tended!to!be!also!the!most!reliable!ones.!
Furthermore,!the!mostMvariable!CpGs!were!overrepresented!in!the!open!sea!and!the!shore!of!
CpG!islands!as!well!as!in!intergenic!regions.!They!were!also!more!likely!to!show!significant!
association!signals!when!investigating!methylation!quantitative!trait!loci!(meQTL)!and!
calculating!associations!with!age!and!sex.!This!natural!epigenetic!variation!may!be!further!
studied!in!EWAS,!such!as!those!related!to!neuropsychiatric!traits.!
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Methods!and!Material!
Subjects!!
The!subjects!included!in!this!study!(N"=!568;!mean!age!23.8y,!18.3!–!38.8;!59!%!females)!
represent!a!subset!of!an!ongoing!study,!which!was!previously!described!e.g.!in!(16;!17).!All!
participants!received!general!information!about!the!study!and!gave!their!written!informed!
consent.!The!ethics!committee!of!the!Cantons!of!BaselMStadt!and!BaselMLandschaft!approved!the!
experiment.!For!additional!information!regarding!the!general!study!design!see!the!
supplementary!material.!!
!
Affymetrix!SNP!6.0!based!genotyping!
SNP!genotyping!for!all!samples!was!performed!as!described!in!the!GenomeMWide!Human!
SNP!Nsp/Sty!6.0!User!Guide!(Affymetrix,!Santa!Clara,!CA!USA;!see!supplemental!material).!The!
mean!callMrate!per!subject!was!98.7!%!(90.1!%!–!99.7!%).!After!outlier!detection!and!pruning,!we!
kept!N!=!533!subjects!and!N"=!185,145!SNPs!for!the!association!analyses!(see!supplementary!
material).!
!
HumanMethylation!Infinium!450K!BeadChip!based!methylation!analyses!
MicroarrayMbased!DNA!methylation!analysis!was!performed!at!ServiceXS!(ServiceXS!B.V.,!
Leiden,!The!Netherlands)!on!the!HumanMethylation450!BeadChip!(Illumina,!Inc.,!San!Diego,!CA,!
U.S.A).!Preprocessing!was!done!independently!for!the!two!batches!of!the!main!sample!(N!=!568)!
and!the!two!batches!of!the!technical!replicates!sample!(N!=!145;!for!additional!information!see!
supplementary!material).!Data!were!extracted!and!analyzed!from!the!generated!idat!files!using!
the!R!package!RnBeads!version!0.99.9!(21).!CpG!annotation!was!based!on!the!manufactures!
annotation!file!(HumanMethylation450_15017482_v.1.2).!During!preprocessing,!the!background!
was!subtracted!using!the!“noob”!method!in!the!methylumi!package!(22).!We!used!the!SWAN!
algorithm!(23)!for!normalization.!!
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The!following!probe!categories!were!excluded!from!the!final!data!sets,!based!on!the!
annotation!provided!within!the!RnBeads!package:!nonMCpG!context!probes,!probes!with!a!SNP!
mapping!directly!to!the!target!CpG!site,!as!well!as!probes!with!three!and!more!SNPs!mapping!
within!the!50mer!probe!(MAF!threshold!was!set!to!0.01;!N!=!18,998!CpGs;!see!Figure!3),!
gonosomal!probes!(N!=!11,473!CpGs),!nonMspecific!probes.!Using!the!Greedycut!algorithm,!we!
iteratively!removed!the!probes!and!data!sets!of!the!highest!impurity!(p!<!0.05).!!
Postprocessing!was!done!for!each!sample!(main!sample!and!technical!replicates!sample)!
separately,!combining!the!βMvalues!of!the!preprocessed!data!for!the!two!available!batches!per!
sample.!The!βMvalues!were!processed!stepMbyMstep!in!order!to!correct!for!further!influential!
factors!as!follows:!1)!using!logitMtransformation!(MMvalue,!(24);!done!with!the!RMpackage!car!
(25));!2)!zMtransformation!per!plate!(correcting!for!plate!and!batch!effects);!3)!regressing!out!
the!first!8!axis!of!a!principal!component!analysis!(PCA).!The!PCA!was!based!on!all!subjects!per!
sample!and!all!CpGs!with!no!missing!values!(>95%!of!the!included!CpGs;!done!with!the!RM
package!pcaMethods!(26)).!!
The!accepted!missing!rate!per!CpG!was!set!to!<!5%.!If!not!already!excluded!before,!we!
further!excluded!probes!associated!to!sex!chromosomes,!polymorphic!probes!or!multiMmapping!
probes!(Nmax!=!63’974)!based!on!the!annotation!files!provided!from!Price!(27)!and!Chen!(28).!
Only!CpGs!surviving!all!filtering!steps!in!both!samples!were!used!(N!=!396’833).!!
We!performed!a!crossMplatform!validation!for!the!genotyping!and!methylation!data!(see!
supplementary!material).!
!
Technical!replication!analyses!
We!used!Pearson!correlation!coefficients!for!all!analyses.!On!methylome!level,!we!
calculated!pairwise!comparisons!for!all!available!CpGs!based!on!the!βMvalues.!These!pairwise!
comparisons!were!done!for!DNA!derived!from!the!identical!(one!comparison!for!each!subject,!
N!=!145!comparisons!in!total;!withinMsubject!comparison)!or!from!differing!DNA!(288!
comparisons!for!each!subject,!N!=!41’760!comparisons!in!total;!betweenMsubject!comparison).!!
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On!singleMCpG!level!we!did!pairwise!comparisons!separately!for!each!CpG,!which!
resulted!in!N!=!396’833!correlation!coefficients.!This!analysis!was!done!after!applying!all!pre!
and!postprocessing!steps.!To!further!evaluate!the!distribution!of!the"N!=!396’833!rMvalues,!we!
applied!a!Gaussian!fit!allowing!up!to!5!overlapping!Gaussian!distributions!by!using!the!optimx!
function!in!R!(settings:!method!LMBFGSMB,!ndeps!0.0001,!maxit!40’000).!The!minimum!and!
maximum!values!were!restricted!to!M1!≥!m!≤!1,!0!≥!sd!≤!1!and!0!≥!p!≤!1.!The!starting!values!were!
as!follows:!m!=!c(0,!0.5,!0.6,!0.7,!0.8);!sd!=!0.12;!p!=!c(0.6,!0.1,!0.1,!0.1,!0.1).!
To!obtain!a!random!rMdistribution!for!a!sample!size!of!N!=!145!subjects,!we!repeatedly!
(N!=!400’000!times)!generated!two!standard!normal!random!variables!(length!of!145!each)!and!
calculated!r!between!these!two!variables.!!
!
Association!analyses!
The!CpG!methylation!data!used!for!the!association!analyses!was!based!on!all!pre!and!
postprocessing!steps.!The!SNPMassociation!studies!were!performed!on!a!genomeMwide!scale!for!
all!N!=!396’833!CpGs!separately!assuming!an!additive!genetic!model!and!applying!an!epiM
genomeMwide!Bonferroni!correction!(α!=!0.1%,!correcting!for!1,000,000!x!396’833!tests,!
resulting!in!pbonf!<!2.5!x!10M15).!For!the!cisManalyses,!we!used!a!less!stringent!significance!
threshold!pcis!<!1!x!10M5!(α!=!1%,!correcting!for!at!least!1,000!independent!tests!per!CpG).!!
To!evaluate!the!associations!with!sex!and!age,!we!calculated!a!single!linear!model!for!
each!CpG,!including!sex!and!age!as!independent!variables!(per!independent!variable!α!=!5%,!
396’833!independent!tests,!p!<!1.3!x!10M7).!
!
Software!
If!not!mentioned!differently,!analyses!were!conducted!in!R!(version:!2.15.1!and!higher,!R!
Development!Core!Team!2012)!or!PLINK!(18).!!
!
!
!
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Results!
In!the!current!study,!we!investigated!the!methylome!and!single!CpG!signal!in!a!large!
sample!(N!=!568;!main!sample)!of!healthy!young!adults.!For!N!=!145!subjects,!a!technical!
replication!was!available,!based!on!the!identical!DNA!derived!from!blood!(technical!replicates!
sample).!The!two!datasets!of!these!subjects!were!used!for!all!reliability!analyses.!The!main!
sample!and!technical!replicates!sample!were!processed!independently,!starting!from!identical!
DNA!specimens.!Based!on!SNPMdata,!N!=!533!subjects!out!of!the!main!sample!were!identified!as!a!
homogenous!subMsample!of!European!ancestry!(association!sample;!see!supplementary!
material),!and!thus!were!used!for!all!association!analyses!that!were!performed!for!validation.!!
!
MethylomeKwide!reliability!analyses!
Based!on!the!βMdistribution!on!methylomeMwide!level!(Figure!1A),!we!observed!high!
signal!reproducibility!of!technical!replicates!(N!=!145!pairs,!average!r!=!0.997,!rmin!=!0.990,!
rmax"=!0.999;!see!Figure!1B!for!one!example).!This!was!in!agreement!with!previous!reports!(2;!
12).!However,!estimated!signal!similarity!between!DNA!of!different!subjects!(N!=!41’905!pairs!of!
betweenMsubject!comparisons),!also!suggested!high!signal!consistency!on!the!methylomeMwide!
level!(average!r!=!0.994,!rmin!=!0.985,!rmax"=!0.997;!see!Figure!1C!for!one!example).!For!each!of!the!
datasets!separately!we!tested,!which!of!the!remaining!N!=!289!datasets!showed!the!highest!
similarity!on!methylomeMwide!level.!In!91!%!of!these!comparisons,!the!highest!similarity!was!
obtained!for!its!technical!replicate,!thus!the!identical!DNA.!!
!
Estimation!of!natural!occurring!variation!on!single!CpG!level!
With!the!replication!analysis!on!singleMCpG!level!we!aimed!to!detect!the!mostMvariable!
CpGs!in!the!investigated!population.!!Given!the!sample!size!of!N!=!145,!we!were!adequately!
powered!(95!%)!on!a!nominal!significance!level!(5!%)!to!detect!a!reliability!r!=!0.29,!which!
corresponds!to!a!natural!epigenetic!variation!of!8.6!%.!
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Taking!all!N!=!396’833!CpGs!into!account,!the!average!r"per!singleMCpG!was!0.191!(rmin!=!M
0.361,!rmax"=!0.988).!Figure!2A!shows!the!distribution!of!rMvalues!across!all!N!=!396’833!CpGs.!To!
further!examine!this!distribution,!we!applied!a!Gaussian!mixture!model!allowing!up!to!five!
Gaussian!distributions!(Figure!2A).!The!result!of!the!Gaussian!mixture!model!indicated!that!for!
approx.!53!%!of!the!CpGs!the!observed!signal!variability!was!mainly!based!on!random!or!
technical!variance!in!our!study!(red!subMdistribution!Figure!2A);!the!majority!of!these!CpGs’!rM
values!were!below!~!0.3.!This!was!further!corroborated!by!comparing!the!r!distribution!of!these!
CpGs!to!a!distribution!of!rMvalues,!which!were!based!on!generated!random!data!sets!(see!Figure!
2B).!!
For!CpGs!with!r!≥!0.3!(N!=!100’564;!for!an!example!see!Figure!1E)!we!assumed!a!
significant!underlying!natural!epigenetic!variation.!These!CpGs!exhibited!a!higher!interM
individual!variability!in!comparison!to!CpGs!with!an!r!<!0.3!(see!Figure!3!and!Figure!1D).!
Accordingly,!we!classified!the!CpGs!with!r!≥!0.3!as!the!mostMvariable!CpGs.!The!signal!of!CpGs!
with!an!r!<!0.3!most!likely!comprised!a!mixture!of!two!different!categories:!random!signals!or!
signals!with!very!low!natural!epigenetic!variation!(~2/3!of!all!CpGs!below!r!=!0.3;!for!an!
example!see!Figure!1F)!and!signals!with!a!medium!to!low!natural!epigenetic!variation!(~1/3!of!
all!CpGs!below!r!=!0.3;!see!lightMgreen!subMdistribution!in!Figure!2A).!!
!
Association!analyses!
Having!detected!CpGs!that!show!considerable!amounts!of!naturally!occurring!variation!
in!the!investigated!population,!we!next!assessed!the!phenotypic!relevance!of!such!variation!by!
means!of!significant!hits!in!association!studies!using!CpG!methylation!as!dependent!variable.!It!
has!already!been!demonstrated!that!DNA!methylation!can!be!influenced!by!genetic!variants!(29;!
30),!as!well!as!sex!and!age!(31;!32).!Hence,!we!calculated!EWAS!for!genetic!variants,!sex!and!age!
in!the!association!sample!(N!=!533).!!
!
!
!
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meQTL!analysis!
To!investigate!the!effect!of!SNPs!on!singleMCpG!methylation!levels!(meQTL),!we!
performed!genomeMwide!association!studies!on!all!396’833!CpGs.!By!applying!a!stringent!
Bonferroni!correction!(p!<!2.5!x!10M15)!we!identified!a!total!of!N!=!56’319!significant!CpGMSNP!
associations,!based!on!N!=!25’140!unique!SNPs!and!N!=!31’135!unique!CpGs.!As!expected!(29;!
30),!most!of!the!top!meQTLs!were!in!cis!of!the!investigated!CpG!(±!3.5!Mb!96.7!%).!Of!note,!the!
more!reliable!CpGs!were,!the!more!likely!they!showed!a!significant!meQTL!(Figure!4A).!
Given!that!most!of!the!significant!signal!appeared!in!close!chromosomal!proximity,!we!
restricted!the!subsequent!analysis!to!a!±!3.5!Mb!window!surrounding!the!investigated!CpG!(cis"
analysis)!and!applied!a!less!stringent!pMvalue!threshold!(p!<!1!x!10M5).!This!analysis!yielded!a!
total!of!N!=!228’559!meQTLs,!based!on!N!=!65’732!unique!SNPs!and!72’310!unique!CpGs.!Again,!
the!more!reliable!the!CpG!was,!the!more!significant!association!signals!could!be!revealed!(see!
Figure!4B).!In!the!CpGs!with!the!highest!r"(average!r!=!0.81;!see!Fig!4B)!69.2!%!of!all!CpGs!
revealed!at!least!one!significant!meQTL!in!cis.!!
!
Association!with!sex!and!age!
The!analyses!revealed!significant!associations!with!sex!(N!=!6’827!CpG)!and!age!(N!=!405!
CpGs).!Similar!to!the!previous!analyses,!also!here!more!reliable!CpGs!were!more!likely!to!show!
significant!association!results!(see!Figure!4C!and!Figure!4D).!Of!note,!only!autosomal!CpGs!were!
used!for!all!analysis!(see!Methods).!!
!
To!summarize,!a!wellMpowered!replication!analysis!on!single!CpG!level!identified!CpGs!
with!substantial!interMindividual!variability,!suggesting!a!medium!to!large!natural!epigenetic!
variation!for!the!investigated!population.!Furthermore,!the!association!analyses!suggest!that!
these!mostMvariable!CpGs!are!additionally!more!likely!to!yield!significant!association!results.!
!
!
!
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Location!of!the!mostKvariable!CpGs!
CpGs!were!classified!with!respect!to!the!genomic!location!in!the!following!categories:!
open!sea,!shore,!shelf!and!island.!As!depicted!in!Figure!5,!the!mostMvariable!CpGs!were!
overrepresented!in!open!sea!and!shore,!and!underrepresented!in!CpG!islands.!This!is!in!
accordance!with!the!finding!that!the!mostMvariable!CpGs!were!also!overrepresented!in!
intergenic!regions.!
!
!
! !
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Discussion!
!
In!the!present!study!we!performed!comprehensive!reliability!analyses!of!the!
HumanMethylation!450!K!array!in!a!large!cohort!of!healthy!young!adults.!The!singleMCpG!
analyses!revealed!reliable!signals!for!25%!of!the!examined!CpGs,!suggesting!a!medium!to!large!
common!epigenetic!variation!(>!8.6%)!in!the!investigated!population.!These!mostMvariable!CpGs!
were!more!likely!to!reveal!significant!association!signals.!The!majority!of!those!CpGs!was!
significantly!associated!with!meQTLs,!suggesting!a!considerable!contribution!of!genetic!
variation!to!the!CpGs’!variability.!The!mostMvariable!CpGs!were!additionally!overMrepresented!in!
open!sea!and!shelf!genomic!regions,!as!well!as!in!intergenic!regions.!
The!technical!replication!analyses!revealed!a!highly!consistent!signal!on!methylomeM
wide!level.!However,!replication!analysis!on!a!singleMCpG!level!can!help!identifying!the!mostM
variable!CpGs!that!show!common!epigenetic!variation!in!the!investigated!population.!It!is!
important!to!stress!that!we!cannot!draw!final!conclusions!with!regard!to!CpGs!that!showed!no!or!
very!low!variability.!Variability!of!such!CpGs!may!change!as!a!function!of!sample!size,!tissue!
selection,!samples’!environmental!background,!genetic!background,!or!disease!status.!By!
analyzing!a!large!sample!of!healthy!young!adults!in!one!tissue!(i.e.!blood)!we!most!likely!
estimated!a!lowerMbound!variability!for!singleMCpGs.!Yet,!these!results!may!serve!as!a!baseline!
reference!for!the!naturally!occurring!epigenetic!variation!of!specific!CpGs.!Of!note,!our!meQTL!
results!are!in!line!with!previous!studies!(33;!34)!and!point!to!the!fact!that!genetic!background!
significantly!contributes!to!the!mostMvariable!CpG!methylation!signal.!
Lack!of!reliability!on!a!singleMCpG!level!in!our!sample!may!reflect!a!truly!invariant!signal!
(e.g.!the!CpG!is!highly!methylated!in!all!subjects),!for!which!the!measured!variability!is!only!due!
to!chance.!However,!failure!to!detect!systematic!variance!can!be!caused!also!by!the!specifics!of!
the!microarray!technology,!including!a!fixed!and!limited!signal!resolution!(2).!Sequencing!
technologies!can!bypass!this!issue!via!customized!signal!resolution,!e.g.!by!optimizing!
sequencing!depth!(35).!Increasing!sequencing!depth,!however,!increases!costs,!while!still!being!
faced!with!the!challenges!of!signal!reliability.!
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Performing!technical!replication!is!a!considerable!cost!factor.!Therefore,!it!is!crucial!to!
discuss!the!relation!between!benefits!and!costs!of!such!a!replication!approach!(10;!36;!37).!If!the!
study!design!emphasizes!the!comparison!of!quite!distinct!states,!like!a!caseMcontrol!design!in!
cancer!research,!it!might!prove!more!efficient!to!increase!sample!size!rather!than!performing!
technical!replications.!Yet,!if!the!aim!is!to!perform!quantitative!trait!analysis!in!a!sample!drawn!
from!a!homogenous!population,!determining!the!mostMvariable!signals!can!considerably!help!
optimizing!the!detection!rate!and!the!probability!of!observing!trueMpositive!findings.!!
Taken!together,!our!results!indicate!that!the!Illumina!Infinium!Human!Methylation!450K!
signals!are!reliable!and!valid,!both!on!a!methylomeMwide!and!on!a!singleMCpG!level.!Importantly,!
a!relevant!percentage!(>25!%)!of!single!CpGs!shows!a!medium!to!strong!common!epigenetic!
variation!in!a!homogenous!sample!of!healthy!young!adults!(see!supplementary!table!1).!These!
findings!could!serve!as!a!baselineMdetermination!of!CpGs!that!show!natural!epigenetic!variation!
in!healthy!humans.!A!strong!enrichment!of!meQTLs!for!the!mostMvariable!CpGs!additionally!
suggests!that!a!significant!proportion!of!common!DNA!methylation!may!be!shared!across!
tissues.!These!findings!could!be!of!special!relevance!for!studies!of!complex!phenotypes,!as!in!the!
case!of!neuropsychiatric!disorders!that!often!rely!on!proxy!tissue.!
!
!
!!
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Figures!
!
Figure!1:!Methylation!signal!distributions!and!replication!analyses.!(A)!Beta!distribution!on!
methylome!level,!shown!for!the!DNA!of!two!different!subjects.!For!the!first!subject,!both!
methylome!data!sets,!from!the!main!sample!and!from!the!technical!replication!sample,!are!
shown.!Beta!values!on!methylome!level!plotted!against!each!other!from!(B)!the!same!subject!
and!(C)!two!different!subjects.!(D)!Beta!distribution!shown!for!two!distinct!CpGs,!separately!for!
the!main!and!the!technical!replicates!sample.!Data!of!the!main!sample!is!restricted!to!the!
N!=!145!subjects,!which!also!appear!in!the!technical!replicates!sample.!(E!and!F)!Beta!values!of!
two!distinct!CpGs!plotted!against!each!other!for!all!N!=!145!subjects!with!available!data!in!the!
main!sample!and!technical!replication!sample.!r:!Pearson!correlation!coefficient.!
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Figure!2:!Replication!analysis!on!singleKCpG!level.!(A)!The!r!distribution!based!on!all!
N!=!396’833!CpGs!is!depicted!in!black.!Results!of!the!Gaussian!fit!are!depicted!in!grey!and!
colored!lines.!The!legend!shows!for!each!estimated!subMdistribution!the!percentage!of!CpGs,!the!
center!(m)!and!the!standard!deviation!(sd).!(B)!Superimposition!of!an!r!distribution!based!on!
random!signals!to!the!fitted!Gaussian!distribution!with!the!mean!closest!to!zero!(as!represented!
by!the!red!curve!in!panel!A).!The!randomly!generated!distribution!is!based!on!standard!normal!
random!variables!(length!N!=!145)!and!was!adjusted!by!the!corresponding!probability!of!
random!probes!from!the!Gaussian!fit!(53!%).!Vertical!dotted!gray!lines!depict!the!center!of!a!
random!distribution!(m!=!0)!and!an!r!of!0.3.!Above!r!=!0.3!it!is!unlikely!that!a!CpG!shows!a!signal!
variability!based!on!random!signals!only.!
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Figure!3:!Density!distributions!of!the!beta’s!mean!and!standard!deviation!(sd),!depending!
on!the!estimated!variability!of!the!CpGs.!CpGs!that!were!classified!as!mostMvariable!in!the!
replication!analysis!on!single!CpG!level!were!less!likely!to!show!extreme!betaMvalues!(A)!and!
showed!a!wider!distribution!(B).!!
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Figure!4:!Association!analyses!results.!CpGs!were!ordered!with!respect!to!their!technical!
replicate!r,!and!grouped!into!15!equally!sized!bins!of!~26’450!CpGs.!On!the!xMaxis,!the!bars!are!
plotted!at!the!average!r!per!group.!On!the!yMaxis,!the!percentage!of!hits!within!the!given!group!is!
depicted.!(A)!Percentage!of!CpGs,!with!at!least!one!genomeMwide!BonferroniMcorrected!(p!<!2.5!x!
10M15!)!genomeMwide!SNPMhit!(meQTL).!(B)!Percentage!of!CpGs,!with!at!least!one!meQTL!in!cis"
(±!3.5!Mb)!upon!a!more!liberal!pMvalue!threshold!of!p!<!1!x!10M5.!Percentage!of!CpGs!that!showed!
a!significant!association!with!age!(C)!or!sex!(D).!
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!
Figure!5:!Genomic!location!of!the!mostKvariable!CpGs.!The!mostMvariable!CpGs!(r!≥!0.3)!(A,!
C)!in!comparison!CpGs!showing!less!common!variation!(r!<!0.3)!(B,!D)!were!overrepresented!in!
open!sea!and!shore!as!well!as!in!intergenic!regions.!
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Supplemental Material 
 
1!StudyKdesign!
Aim!of!the!study!is!to!recruit!large!samples!of!healthy!young!adults!for!assessing!
cognitive!performance!measurements,!personality!traits,!functional!and!anatomical!magnetic!
resonance!imaging!and!genetics!(based!on!saliva!DNA)!at!the!timeMpoint!of!the!main!
investigation.!Subjects!were!reMinvited!to!an!additional!blood!and!saliva!sampling.!The!time!
point!of!this!second!investigation!was!on!average!348!days!(min!1!day;!max!1384!days;!median!
314!days)!after!the!main!investigation:!subject’s!DNA!was!collected!between!midday!and!
evening!(mean!time!=!2:30!p.m.,!range!1:00!p.m.!–!8.00!p.m.);!saliva!and!blood!sampling!took!
place!within!1!hour.!Subjects!were!free!of!any!neurological!or!psychiatric!illness,!and!did!not!
take!any!medication!(apart!from!oral!contraception)!at!both!time!points!of!the!study.!Women!
using!different!methods!of!hormonal!contraceptives!(e.g.,!oral,!spiral,!patch)!and!naturally!
cycling!women!were!included!without!restrictions.!
!
!
2!CrossKdataset!Validation!
A!perMsubject!crosscheck!between!phenotypic!data,!methylation!data!and!genetics!data!
was!performed!using!the!reported!sex!and!the!sexMpredictions!based!on!the!arrays!data,!as!well!
as!matching!of!all!SNPs!represented!on!the!Illumina!450K!array!to!the!corresponding!Affymetrix!
SNP!6.0!or!imputation!derived!genotype!calls.!This!crosscheck!allowed!an!unambiguous!
assignment!of!each!methylation!dataset!to!the!corresponding!genetic!and!phenotypic!dataset.!
!
!
! !
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3!Affymetrix!SNP!6.0!based!genotyping!
SNP!genotyping!
Genotyping!was!performed!using!DNA!obtained!from!saliva.!Saliva!samples!were!
collected!using!the!Oragene!DNA!Kit!(DNA!Genotek,!Kanata,!Canada).!Saliva!DNA!was!extracted!
from!the!Oragene!DNA!Kit!using!the!standard!precipitation!protocol!recommended!by!the!
producer.!Genomic!DNA!concentration!was!adjusted!to!50ng/μl!in!water.!Digestion!was!done!
with!250ng!of!DNA,!in!parallel!with!10!units!of!Sty!I!and!Nsp!I!restriction!enzymes!(New!England!
Biolabs,!Knowl!Piece,!UK)!for!2!hours!at!37°C.!Following,!enzyme!specific!adaptor!
oligonucleotides!were!ligated!onto!the!digested!ends!with!T4!DNA!Ligase!for!3!hours!at!16°C.!
After!adjusting!volume!to!100μl!with!water,!10μl!of!the!diluted!ligation!reactions!were!subjected!
to!PCR.!Three!PCR!reactions!of!100μl!were!performed!for!Sty!digested!products!and!four!PCR!
reactions!for!Nsp.!PCR!was!performed!with!Titanium!Taq!DNA!Polymerase!(Clontech,!Mountain!
View,!CA)!in!the!presence!of!4.5!µM!PCR!primer!002!(Affymetrix,!Santa!Clara,!CA),!350!µM!each!
dNTP!(Clontech),!1M!GMC!Melt!(Clontech),!and!1X!Titanium!Taq!PCR!Buffer!(Clontech).!Following!
cycling!parameters!were!used:!94°C,!3!min;!30!x!(94°C,!30!s;!60°C,!45!s;!68°C,!15!s);!68°C,!7!min.!
PCR!products!expected!in!the!range!size!between!200M1100!bp!were!verified!using!2%!
(weight/volume)!TBE!gel!electrophoresis.!PCR!products!were!pooled!and!purified!with!the!
Filter!Bottom!Plate!(Millipore,!Billerica,!MA;!P/N!MDRLN0410)!using!Agencourt!AMPure!XP!
Beads!(Beckman!Coulter,!Fuillerton,!CA).!Quantification!of!purified!PCR!products!was!done!on!a!
Zenith!200rt!microplate!reader!(AnthosMLabtec,!Cambridge,!UK),!with!average!yield!of!4!to!
5μg/μl!per!sample.!Subsequently,!the!SNP!Nsp/Sty!5.0/6.0!Assay!Kit!(Affymetrix)!was!used.!For!
the!fragmentation!around!250!μg!of!purified!PCR!products!was!digested!using!0.5!units!of!
DNAse!I!at!37°C!for!35!minutes.!Average!size!of!fragmentation!products!less!than!180!bps!was!
verified!using!4%!(weight/volume)!TBE!gel!electrophoresis.!Following,!the!DNA!was!end!labeled!
with!105!units!of!terminal!deoxynucleotidyl!transferase!at!37°C!for!4!hours.!The!labeled!DNA!
was!then!hybridized!onto!GenomeMWide!Human!SNP!6.0!Array!at!50°C!for!18!hours!at!60!rpm.!
The!hybridized!array!was!washed,!stained,!and!scanned!according!to!the!manufacturer’s!
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! MILNIK!–!27!
In!order!to!obtain!high!purity!DNA!prior!to!bisulfite!conversion,!isolated!DNA!samples!were!
additionally!reMpurified.!For!this!purpose,!2µg!of!DNA!isolated!with!QIAmp/Oragene!procedure,!
was!incubated!overnight!at!50°C!with!proteinase!K!(Lysis!buffer:!30!mM!Tris·Cl;!10!mM!EDTA;!
1%!SDS,!pH!8.0;!150ng/µl!Proteinase!K),!agitated!by!gentle!orbital!shaking.!Next,!the!DNA!was!
purified!using!Genomic!DNA!Clean!&!Concentrate!Kit!(Zymo!Research,!Irvine,!CA).!The!quality!
and!concentration!of!DNA!were!assessed!using!gel!electrophoresis,!NanoDrop!NDM!1000!
(Thermo!Scientific,!Waltham,!MA)!and!fluorometry!measurements!(Qubit!dsDNA!BR!Assay!Kit;!
Invitrogen,!Carlsbad,!CA),!respectively.!
The!bisulfite!conversion!was!performed!with!500!ng!genomic!DNA!input!using!the!EZ!
DNA!Methylation!Gold!Kit!(Zymo!Research).!A!bisulfite!conversion!quality!control!on!the!probes!
was!performed!with!DNA!qPCR!reaction!and!subsequent!melting!curve!analysis!(20).!The!
bisulfiteMconverted!DNA!was!processed!and!hybridized!to!the!HumanMethylation450!BeadChip!
(Illumina,!Inc,!San!Diego,!CA),!according!to!the!manufacturer's!instructions.!The!BeadChip!
images!were!scanned!on!the!iScan!system.!!
All!DNA!probes!isolated!from!blood!were!randomized!and!processed!in!8!plates,!with!95!
probes!per!plate!and!1!additional!control!probe.!The!plates!were!processed!in!3!batches,!
comprising!3,!4!and!1!plate,!respectively.!Main!sample:!The!568!probes!were!processed!on!6!
plates!(batch!1:!2!plates;!batch!2:!4!plates).!Technical!replication!sample:!The!145!probes!were!
processed!on!2!plates!(batch!1:!1!plate;!batch!3:!1!plate).!
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5 Discussion 
Complex data analyses offer great opportunities to gain insight in complex 
human phenotypes. However, analysis and outcome are also challenging by their 
complexity. In the current thesis I presented three different works dealing with 
complex data analytical strategies. The main goal behind all three of them was not to 
build up comprehensive theoretical frameworks, but to perform more preparatory 
analytical steps. The meta-analysis validated and extended a genetic association 
finding of the SNP rs17070145 with human memory performance by accumulating 
information of about 6 years of research performed worldwide. The heritability 
analysis verified that a common SNP-chip array is an appropriate dataset to perform 
more complex genetic analyses with human working memory performance. The 
analysis of common epigenetic variation validated the DNA CpG methylation dataset 
in the context of complex analyses with mentally healthy young adults. Additionally, 
when comparing the outcomes of all three analyses, they also shed light on the 
varying complexity of putative endophenotypes in human research. 
In 2006, Papassotiropoulos et al. reported an association of the SNP 
rs17070145 located in KIBRA with episodic memory performance (Papassotiropoulos 
et al., 2006), based on rather small sample sizes (initial sample N = 333; replication 
sample Europe N = 424; replication sample USA N = 256). Although replicated twice 
within the same study, this might still be a false positive finding. However, based on 
the meta-analytical approach that combined data of 17 independent studies, it was 
possible to verify and extend the initial finding: In the meta-analysis, the SNP 
rs17070145 was not only associated with episodic (r = 0.068) but also with working 
memory performance (r = 0.035). As expected, the estimated effect sizes were 
considerably smaller than the initially reported effect sizes (rmin = 0.13, rmax = 0.22).  
The reported effect size estimates of the meta-analyses appear rather small, 
and might be called negligible. However, it is important to note that the strength of a 
large-scale cross-sectional study is to search for promising target molecules based on 
naturally occurring genetic variation. As a next step these promising findings should 
be accompanied by more targeted research that investigates potential causal 
mechanisms behind the identified covariance. For KIBRA, several promising studies 
based on different study designs have been performed since 2006. As one example, in 
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2011 Makuch et al. reported that KIBRA knockout mice show an impairment in 
learning and memory (Makuch et al., 2011). Later on Duning et al. (2013) could show, 
that the identified SNP is in linkage disequilibrium with two exonic SNPs 
(rs3822600, rs3822659) that affect KIBRAs C2 domain (Duning et al., 2013). Also 
based on knockout mice, Vogt-Eisele et al. (2014) additionally provided a potential 
mechanism how KIBRA act on memory via stabilization of the synaptic protein 
kinase M ζ (Vogt-Eisele et al., 2014). So from this global perspective, the initial 
finding successfully stimulated more targeted research on KIBRA as a quite 
promising target molecule for memory performances.  
For the N-Back working memory task, it was further possible to identify a 
significant SNP-chip heritability based on N = 2’298 unrelated healthy individuals. 
As one would expect, there was no prominent contribution of e.g. one single 
chromosome only, but an equal distribution of heritability estimates over 
chromosomes, as expected for highly polygenetic traits. Heritability estimates for 2-
Back derived working memory performance ranged between 31 % (s.e. 14 %) and 
41 % (s.e. 14 %). This is slightly above the SNP-chip heritability estimates derived for 
related neuropsychiatric diseases (Lee et al., 2013). Recently, based on a bivariate 
analysis a shared genetic variability between schizophrenia and performance IQ of 
about 14 % could be revealed in a large (N = 11’853) UK schizophrenia sample 
(Hubbard et al., 2015). For future research, a comparable analysis of genetic 
covariance between schizophrenia and working memory performance would be of 
interest. 
The results from the estimation of common variation for the DNA CpG 
methylation data point to the fact that a carful investigation of the primary data 
might help improving the signal-to-noise ratio in complex analytical situations. Only 
about 1/3 of the CpGs showed a considerable amount of common variation in the 
investigated population of healthy young adults. Importantly, the amount of variation 
was informative for the association studies that were performed for further 
validation. These results may serve as baseline information for further studies. If a 
CpG already shows a considerable part of common variation in a population of 
healthy young adults, and is additionally associated with disease status, this might be 
a hint that the variation in the CpG is a very general predisposition to the disease, 
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whereas when the variation appears in the time-course of the disease, this might 
rather be a causal epimutation.  
When comparing the outcomes of all three works it becomes obvious that the 
phenotypes memory performance and DNA CpG methylation show a considerable 
difference in their polygenicity, although both are classified as putative intermediate 
phenotypes or endophenotypes. From a theoretical perspective these two have at 
least one considerable difference in nature: DNA methylation can be seen as a filter 
that dynamically modifies the output of the genetic blueprint. It is also known that 
environmental factors may change DNA methylation status. Nevertheless, DNA 
methylation itself has no direct impact on the environment but might modify other 
intermediate phenotypes like brain functioning or functioning of the immune system. 
In contrast to that, differences in memory performance rather reflect the sum of the 
human experiences in combination with brain and body functioning. Besides this 
theoretical view, the difference in the polygenicity of these two phenotypes can nicely 
be seen in the genetic analyses performed: For working-memory performance the 
heritability estimates per chromosome show a polygenetic picture with a large 
amount of common variants being involved. This picture is also confirmed by the 
meta-analysis, in which the estimated effect sizes for one common genetic variant are 
rather small. In contrast to that, for the CpG-methylation data we could show in the 
genetic association analysis that a considerable amount of CpGs has highly significant 
associations with SNPs in close proximity to the CpG only. Adjacent analyses (not 
included in the final paper) could show that in most cases there is only one main 
SNP-signal that is associated with the CpG methylation signal, with a medium to 
large effect size.  
To summarize, complex phenotypes call for complex data analyses strategies. 
However, with these complex analytical approaches one has to find a good balance 
between the need for complexity and the benefit of simplicity. Simplifying the 
research design is a suitable approach to circumvent overwhelmingly complex 
analytical situations. Furthermore a thoughtful investigation of the primary signals is 
a key step before building up more comprehensive theoretical models. The analyses 
reported in this cumulative thesis aimed at performing preparatory analytical steps 
before building up comprehensive theoretical and analytical models. Here, it is 
important to note that neither large amounts of data nor complex data analyses can 
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replace the stimulating function of defining a suitable theoretical model. Bernard 
Forscher (1963) summarizes this in his analogy of a brickyard, where the brickyard 
represents data: What should be avoided is that “no effort was made even to maintain 
the distinction between a pile of bricks and a true edifice” (Forscher, 1963). Hence, to 
achieve knowledge from information in epidemiological oriented research, big data 
and complex analytical strategies should finally be seen as tools to build up suitable 
models of reality, which will be the future directive of my work.  
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